"Term","Jaccard","Odds_Ratio","Fold_Enrichment","PValue","FDR","Genes"
"GO:1901194~negative regulation of formation of translation preinitiation complex",0.0769230769230769,Inf,1518.84615384615,0.000658394530260953,0.0249774637888529,"23521"
"GO:0019550~glutamate catabolic process to aspartate",0.0714285714285714,1636.24640628408,759.423076923077,0.00131638890177155,0.0249774637888529,"2805"
"GO:1902691~respiratory basal cell differentiation",0.0714285714285714,1636.24640628408,759.423076923077,0.00131638890177155,0.0249774637888529,"440193"
"GO:0047801~L-cysteine transaminase activity",0.0714285714285714,1636.24640628408,759.423076923077,0.00131638890177155,0.0249774637888529,"2805"
"GO:0004609~phosphatidylserine decarboxylase activity",0.0714285714285714,1636.24640628408,759.423076923077,0.00131638890177155,0.0249774637888529,"2805"
"GO:0005527~macrolide binding",0.0714285714285714,1636.24640628408,759.423076923077,0.00131638890177155,0.0249774637888529,"2280"
"R-HSA-9636667~Manipulation of host energy metabolism",0.0714285714285714,1636.24640628408,759.423076923077,0.00131638890177155,0.0249774637888529,"2023"
"GO:0006114~glycerol biosynthetic process",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"2805"
"GO:2000630~positive regulation of miRNA metabolic process",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"3265"
"GO:0006532~aspartate biosynthetic process",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"2805"
"GO:0006533~aspartate catabolic process",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"2805"
"GO:0160185~phospholipase C activator activity",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"3265"
"GO:0004069~L-aspartate:2-oxoglutarate aminotransferase activity",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"2805"
"R-HSA-9649913~RAS GTPase cycle mutants",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"3265"
"R-HSA-9753510~Signaling by RAS GAP mutants",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"3265"
"R-HSA-9753512~Signaling by RAS GTPase mutants",0.0666666666666667,817.272008200725,506.282051282051,0.00197398333748433,0.0249774637888529,"3265"
"GO:0006458~'de novo' protein folding",0.0625,530.092543440554,379.711538461538,0.00263117806023827,0.0284523771565878,"2280"
"GO:0004082~bisphosphoglycerate mutase activity",0.0625,530.092543440554,379.711538461538,0.00263117806023827,0.0284523771565878,"5223"
"GO:0004619~phosphoglycerate mutase activity",0.0625,530.092543440554,379.711538461538,0.00263117806023827,0.0284523771565878,"5223"
"65.Integrin_affinity_modulation",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"3265"
"GO:0003383~apical constriction",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"440193"
"GO:0014809~regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"2280"
"GO:0008652~amino acid biosynthetic process",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"2805"
"GO:0016868~intramolecular phosphotransferase activity",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"5223"
"R-HSA-3656535~TGFBR1 LBD Mutants in Cancer",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"2280"
"R-HSA-1169092~Activation of RAS in B cells",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"3265"
"R-HSA-5368598~Negative regulation of TCF-dependent signaling by DVL-interacting proteins",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"440193"
"KW-0617~Plasminogen activation",0.0588235294117647,405.400193361887,303.769230769231,0.00328797329276043,0.0301194590522005,"2023"
"GO:0000413~protein peptidyl-prolyl isomerization",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"2280"
"GO:0090402~oncogene-induced cell senescence",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"3265"
"GO:0045933~positive regulation of muscle contraction",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"2023"
"GO:0004634~phosphopyruvate hydratase activity",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"2023"
"R-HSA-9634635~Estrogen-stimulated signaling through PRKCZ",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"3265"
"R-HSA-1237112~Methionine salvage pathway",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"2805"
"hsa00400_Phenylalanine,_tyrosine_and_tryptophan_biosynthesis",0.0555555555555556,323.919076095458,253.141025641026,0.00394436925766362,0.0323026139665964,"2805"
"GO:1903298~negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"2023"
"GO:1902991~regulation of amyloid precursor protein catabolic process",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"2280"
"GO:0006531~aspartate metabolic process",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"2805"
"GO:0030547~signaling receptor inhibitor activity",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"2280"
"R-HSA-9034864~Activated NTRK3 signals through RAS",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"3265"
"R-HSA-6802953~RAS signaling downstream of NF1 loss-of-function variants",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"3265"
"R-HSA-112412~SOS-mediated signalling",0.0526315789473684,269.706489097506,216.978021978022,0.00460036617744963,0.0333274499442141,"3265"
"GO:0031670~cellular response to nutrient",0.05,232.610243363159,189.855769230769,0.00525596427450559,0.0349663748311964,"1452"
"GO:0010756~positive regulation of plasminogen activation",0.05,232.610243363159,189.855769230769,0.00525596427450559,0.0349663748311964,"2023"
"R-HSA-2428933~SHC-related events triggered by IGF1R",0.05,232.610243363159,189.855769230769,0.00525596427450559,0.0349663748311964,"3265"
"R-HSA-3656534~Loss of Function of TGFBR1 in Cancer",0.05,232.610243363159,189.855769230769,0.00525596427450559,0.0349663748311964,"2280"
"R-HSA-9026519~Activated NTRK2 signals through RAS",0.05,232.610243363159,189.855769230769,0.00525596427450559,0.0349663748311964,"3265"
"GO:0043490~malate-aspartate shuttle",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"2805"
"GO:0062196~regulation of lysosome size",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"282991"
"GO:0042088~T-helper 1 type immune response",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"3265"
"GO:0097345~mitochondrial outer membrane permeabilization",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"282991"
"GO:0070697~activin receptor binding",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"2280"
"R-HSA-9856872~Malate-aspartate shuttle",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"2805"
"R-HSA-3304351~Signaling by TGF-beta Receptor Complex in Cancer",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"2280"
"R-HSA-2179392~EGFR Transactivation by Gastrin",0.0476190476190476,202.935002813732,168.760683760684,0.00591116377110745,0.0356592155948108,"3265"
"GO:0120197~mucociliary clearance",0.0454545454545455,182.091897532672,151.884615384615,0.00656596488941819,0.0379965457149183,"440193"
"GO:0006625~protein targeting to peroxisome",0.0454545454545455,182.091897532672,151.884615384615,0.00656596488941819,0.0379965457149183,"54469"
"GO:0016247~channel regulator activity",0.0454545454545455,182.091897532672,151.884615384615,0.00656596488941819,0.0379965457149183,"2280"
"WP5050:TCA cycle in senescence",0.0454545454545455,182.091897532672,151.884615384615,0.00656596488941819,0.0379965457149183,"2805"
"GO:0061621~canonical glycolysis",0.0625,187.538367491253,144.652014652015,8.34423080771308e-05,0.00901265188074598,"2023, 5223"
"GO:0097250~mitochondrial respirasome assembly",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"192286"
"GO:0006107~oxaloacetate metabolic process",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"2805"
"GO:0051036~regulation of endosome size",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"282991"
"GO:0005528~FK506 binding",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"2280"
"R-HSA-9028731~Activated NTRK2 signals through FRS2 and FRS3",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"3265"
"R-HSA-5655291~Signaling by FGFR4 in disease",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"3265"
"R-HSA-9634285~Constitutive Signaling by Overexpressed ERBB2",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"3265"
"R-HSA-8963693~Aspartate and asparagine metabolism",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"2805"
"R-HSA-8851805~MET activates RAS signaling",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"3265"
"WP5049:Glycolysis in senescence",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"2023"
"WP2333:Trans sulfuration pathway",0.0434782608695652,163.270149199281,138.076923076923,0.00722036785148716,0.0379965457149183,"2805"
"GO:2001171~positive regulation of ATP biosynthetic process",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"2023"
"GO:0034713~type I transforming growth factor beta receptor binding",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"2280"
"R-HSA-171007~p38MAPK events",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"3265"
"R-HSA-9673767~Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"3265"
"R-HSA-2025928~Calcineurin activates NFAT",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"2280"
"R-HSA-9673770~Signaling by PDGFRA extracellular domain mutants",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"3265"
"WP2290:RalA downstream regulated genes",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"3265"
"WP4583:Biomarkers for urea cycle disorders",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"2805"
"WP4629:Aerobic glycolysis",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"2023"
"WP106:Alanine and aspartate metabolism",0.0416666666666667,147.984859498515,126.570512820513,0.0078743728792533,0.0383448821627303,"2805"
"GO:0032926~negative regulation of activin receptor signaling pathway",0.04,136.105450207988,116.834319526627,0.00852798019454082,0.0396566842946707,"2280"
"GO:0072384~organelle transport along microtubule",0.04,136.105450207988,116.834319526627,0.00852798019454082,0.0396566842946707,"282991"
"R-HSA-179812~GRB2 events in EGFR signaling",0.04,136.105450207988,116.834319526627,0.00852798019454082,0.0396566842946707,"3265"
"R-HSA-70263~Gluconeogenesis",0.0540540540540541,148.387624121567,116.834319526627,0.000128897293626872,0.0118157457808676,"2023, 5223"
"WP4628:Aerobic glycolysis augmented",0.04,136.105450207988,116.834319526627,0.00852798019454082,0.0396566842946707,"2023"
"GO:0030705~cytoskeleton-dependent intracellular transport",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"440193"
"GO:0000028~ribosomal small subunit assembly",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"6208"
"GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"2280"
"R-HSA-4839748~Signaling by AMER1 mutants",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"1452"
"R-HSA-180336~SHC1 events in EGFR signaling",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"3265"
"R-HSA-9027284~Erythropoietin activates RAS",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"3265"
"R-HSA-1250347~SHC1 events in ERBB4 signaling",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"3265"
"R-HSA-5467348~Truncations of AMER1 destabilize the destruction complex",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"1452"
"R-HSA-4839744~Signaling by APC mutants",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"1452"
"R-HSA-4839735~Signaling by AXIN mutants",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"1452"
"R-HSA-8849471~PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"3265"
"R-HSA-5467337~APC truncation mutants have impaired AXIN binding",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"1452"
"R-HSA-5467340~AXIN missense mutants destabilize the destruction complex",0.0384615384615385,126.010220624246,108.489010989011,0.00918119001906303,0.0396566842946707,"1452"
"GO:1900226~negative regulation of NLRP3 inflammasome complex assembly",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"GO:0014044~Schwann cell development",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"3265"
"GO:1900029~positive regulation of ruffle assembly",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"3265"
"GO:0005160~transforming growth factor beta receptor binding",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"2280"
"R-HSA-5358751~CTNNB1 S45 mutants aren't phosphorylated",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"R-HSA-5339716~Signaling by GSK3beta mutants",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"R-HSA-9694631~Maturation of nucleoprotein",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"R-HSA-4839743~Signaling by CTNNB1 phospho-site mutants",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"R-HSA-5637810~Constitutive Signaling by EGFRvIII",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"3265"
"R-HSA-5637812~Signaling by EGFRvIII in Cancer",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"3265"
"R-HSA-5358749~CTNNB1 S37 mutants aren't phosphorylated",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"R-HSA-5358747~CTNNB1 S33 mutants aren't phosphorylated",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"R-HSA-5358752~CTNNB1 T41 mutants aren't phosphorylated",0.037037037037037,116.786614115146,101.25641025641,0.00983400257441969,0.0396566842946707,"1452"
"WP534:Glycolysis and gluconeogenesis",0.0545454545454545,139.92546823289,101.25641025641,3.11358880480651e-06,0.00123526295674609,"2023, 2805, 5223"
"GO:0006094~gluconeogenesis",0.0535714285714286,136.683927782328,99.0551839464883,3.32954974864176e-06,0.00123526295674609,"2023, 2805, 5223"
"GO:0042592~homeostatic process",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"23521"
"GO:0060425~lung morphogenesis",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"23521"
"GO:0060347~heart trabecula formation",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"2280"
"GO:0048169~regulation of long-term neuronal synaptic plasticity",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"3265"
"R-HSA-1963640~GRB2 events in ERBB2 signaling",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"3265"
"R-HSA-9034015~Signaling by NTRK3 (TRKC)",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"3265"
"R-HSA-9665348~Signaling by ERBB2 ECD mutants",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"3265"
"R-HSA-9703648~Signaling by FLT3 ITD and TKD mutants",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"3265"
"WP4504:Cysteine and methionine catabolism",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"2805"
"hsa00360_Phenylalanine_metabolism",0.0357142857142857,109.053170763971,94.9278846153846,0.0104864180821002,0.0399021652149657,"2805"
"GO:0048246~macrophage chemotaxis",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"23521"
"GO:0055089~fatty acid homeostasis",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"2805"
"GO:0006536~glutamate metabolic process",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"2805"
"GO:0048490~anterograde synaptic vesicle transport",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"282991"
"GO:0097435~supramolecular fiber organization",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"2280"
"GO:0070411~I-SMAD binding",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"2280"
"R-HSA-196299~Beta-catenin phosphorylation cascade",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"1452"
"R-HSA-2173791~TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"2280"
"R-HSA-5654704~SHC-mediated cascade:FGFR3",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"3265"
"WP3853:ERK pathway in Huntington 39 s disease",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"3265"
"WP3664:Regulation of Wnt B catenin signaling by small molecule compounds",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"1452"
"WP1946:Cori cycle",0.0344827586206897,102.121663116397,89.3438914027149,0.0111384367634796,0.0399261839541152,"5223"
"KW-0324~Glycolysis",0.0434782608695652,107.987248442484,86.7912087912088,0.000235193684226667,0.0158648830632897,"2023, 5223"
"GO:0006103~2-oxoglutarate metabolic process",0.0333333333333333,96.1458771866114,84.3803418803419,0.011790058839822,0.0412652059393769,"2805"
"R-HSA-881907~Gastrin-CREB signalling pathway via PKC and MAPK",0.0333333333333333,96.1458771866114,84.3803418803419,0.011790058839822,0.0412652059393769,"3265"
"R-HSA-210993~Tie2 Signaling",0.0333333333333333,96.1458771866114,84.3803418803419,0.011790058839822,0.0412652059393769,"3265"
"R-HSA-5635838~Activation of SMO",0.0333333333333333,96.1458771866114,84.3803418803419,0.011790058839822,0.0412652059393769,"1452"
"WP4301:Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells",0.0333333333333333,96.1458771866114,84.3803418803419,0.011790058839822,0.0412652059393769,"3265"
"GO:0045104~intermediate filament cytoskeleton organization",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"1452"
"R-HSA-9670439~Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-9669938~Signaling by KIT in disease",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-1236382~Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-5637815~Signaling by Ligand-Responsive EGFR Variants in Cancer",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-5218921~VEGFR2 mediated cell proliferation",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-5654688~SHC-mediated cascade:FGFR1",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-5654719~SHC-mediated cascade:FGFR4",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-9703465~Signaling by FLT3 fusion proteins",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"R-HSA-167044~Signalling to RAS",0.032258064516129,90.8409866919143,79.9392712550607,0.0124412845322774,0.0412686722343987,"3265"
"GO:0034260~negative regulation of GTPase activity",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"3265"
"GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"3265"
"GO:0045182~translation regulator activity",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"6208"
"R-HSA-9671555~Signaling by PDGFR in disease",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"3265"
"R-HSA-5654706~FRS-mediated FGFR3 signaling",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"3265"
"WP5149:Lipid metabolism in senescent cells",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"3265"
"WP732:Serotonin receptor 2 and ELK SRF GATA4 signaling",0.03125,85.9880904826825,75.9423076923077,0.0130921140618876,0.0418721923875888,"3265"
"R-HSA-5621575~CD209 (DC-SIGN) signaling",0.0303030303030303,81.9124997506323,72.3260073260073,0.0137425476495784,0.0435767963931075,"3265"
"R-HSA-5654699~SHC-mediated cascade:FGFR2",0.0303030303030303,81.9124997506323,72.3260073260073,0.0137425476495784,0.0435767963931075,"3265"
"WP4290:Metabolic reprogramming in colon cancer",0.0377358490566038,89.2298060134288,72.3260073260073,0.000339455447362424,0.0179911387102085,"2023, 5223"
"GO:0030490~maturation of SSU-rRNA",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"6208"
"R-HSA-1250196~SHC1 events in ERBB2 signaling",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"3265"
"R-HSA-9665686~Signaling by ERBB2 TMD/JMD mutants",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"3265"
"R-HSA-5654712~FRS-mediated FGFR4 signaling",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"3265"
"R-HSA-5654693~FRS-mediated FGFR1 signaling",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"3265"
"R-HSA-5655332~Signaling by FGFR3 in disease",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"3265"
"KW-0032~Aminotransferase",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"2805"
"WP5046:NAD metabolism in oncogene induced senescence and mitochondrial dysfunction associated senescence",0.0294117647058824,77.9617043998657,69.0384615384615,0.0143925855161648,0.0439477302592359,"2805"
"R-HSA-9637690~Response of Mtb to phagocytosis",0.0285714285714286,74.4134513218442,66.0367892976589,0.015042227882351,0.0453712727183107,"2023"
"R-HSA-9006115~Signaling by NTRK2 (TRKB)",0.0285714285714286,74.4134513218442,66.0367892976589,0.015042227882351,0.0453712727183107,"3265"
"hsa00220_Arginine_biosynthesis",0.0285714285714286,74.4134513218442,66.0367892976589,0.015042227882351,0.0453712727183107,"2805"
"GO:0006096~glycolytic process",0.0338983050847458,77.5260589799698,63.2852564102564,0.000443732278102037,0.0219499566901141,"2023, 5223"
"R-HSA-5654700~FRS-mediated FGFR2 signaling",0.0277777777777778,71.1400860628356,63.2852564102564,0.0156914749687282,0.046386750704368,"3265"
"R-HSA-442982~Ras activation upon Ca2+ influx through NMDA receptor",0.0277777777777778,71.1400860628356,63.2852564102564,0.0156914749687282,0.046386750704368,"3265"
"R-HSA-5654708~Downstream signaling of activated FGFR3",0.0277777777777778,71.1400860628356,63.2852564102564,0.0156914749687282,0.046386750704368,"3265"
"WP4595:Urea cycle and associated pathways",0.0277777777777778,71.1400860628356,63.2852564102564,0.0156914749687282,0.046386750704368,"2805"
"GO:0032438~melanosome organization",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"282991"
"GO:0060155~platelet dense granule organization",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"282991"
"GO:0048027~mRNA 5'-UTR binding",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"6208"
"R-HSA-9664565~Signaling by ERBB2 KD Mutants",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"3265"
"R-HSA-9006335~Signaling by Erythropoietin",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"3265"
"R-HSA-1643713~Signaling by EGFR in Cancer",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"3265"
"R-HSA-166208~mTORC1-mediated signalling",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"2280"
"WP4483:Relationship between inflammation COX 2 and EGFR",0.027027027027027,68.2109833138117,60.7538461538462,0.0163403269957751,0.0465154164738942,"3265"
"hsa01230_Biosynthesis_of_amino_acids",0.0352941176470588,81.6558973236209,60.7538461538462,1.46483474814743e-05,0.00362302461041797,"2023, 2805, 5223"
"GO:0007020~microtubule nucleation",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"282991"
"GO:0055010~ventricular cardiac muscle tissue morphogenesis",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"2280"
"GO:0042026~protein refolding",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"2280"
"GO:0044782~cilium organization",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"440193"
"R-HSA-1227990~Signaling by ERBB2 in Cancer",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"3265"
"R-HSA-5654716~Downstream signaling of activated FGFR4",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"3265"
"KW-0028~Amino-acid biosynthesis",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"2805"
"WP3658:Wnt beta catenin signaling in leukemia",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"1452"
"WP5216:Warburg effect modulated by deubiquitinating enzymes and their substrates",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"5223"
"WP5494:Tyrosine kinase inhibitors in glioblastoma",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"3265"
"WP5496:Targeted therapy in breast cancer",0.0263157894736842,65.6235456141752,58.4171597633136,0.0169887841838616,0.0465154164738942,"3265"
"GO:0035567~non-canonical Wnt signaling pathway",0.0256410256410256,62.9843347171229,56.2535612535613,0.0176368467532415,0.0477610959522088,"440193"
"R-HSA-9635486~Infection with Mycobacterium tuberculosis",0.0256410256410256,62.9843347171229,56.2535612535613,0.0176368467532415,0.0477610959522088,"2023"
"R-HSA-9648002~RAS processing",0.0256410256410256,62.9843347171229,56.2535612535613,0.0176368467532415,0.0477610959522088,"3265"
"WP560:TGF beta receptor signaling",0.0307692307692308,68.6181635485526,56.2535612535613,0.000561673453172757,0.0249774637888529,"2280, 3265"
"GO:0071480~cellular response to gamma radiation",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"3265"
"GO:0090303~positive regulation of wound healing",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"3265"
"GO:0042832~defense response to protozoan",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"3265"
"GO:0051959~dynein light intermediate chain binding",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"440193"
"R-HSA-5654696~Downstream signaling of activated FGFR2",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"3265"
"R-HSA-9682385~FLT3 signaling in disease",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"3265"
"WP2583:T cell receptor and co stimulatory signaling",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"1452"
"WP2643:Nanoparticle mediated activation of receptor signaling",0.025,60.6578517647063,54.2445054945055,0.018284514924061,0.0479403182814604,"3265"
"GO:0090314~positive regulation of protein targeting to membrane",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"3265"
"GO:0035025~positive regulation of Rho protein signal transduction",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"1452"
"R-HSA-5654687~Downstream signaling of activated FGFR1",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"3265"
"R-HSA-2424491~DAP12 signaling",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"3265"
"R-HSA-1614635~Sulfur amino acid metabolism",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"2805"
"R-HSA-186763~Downstream signal transduction",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"3265"
"WP3972:PDGFR beta pathway",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"3265"
"WP2870:Extracellular vesicle mediated signaling in recipient cells",0.024390243902439,58.4989808198349,52.3740053050398,0.0189317889163506,0.0482728088520005,"3265"
"WP4816:TGF beta receptor signaling in skeletal dysplasias",0.0289855072463768,63.7222709398402,52.3740053050398,0.000647846387562445,0.0249774637888529,"2280, 3265"
"GO:0008089~anterograde axonal transport",0.0238095238095238,56.4900579260545,50.6282051282051,0.0195786689500341,0.0494128311596099,"282991"
"GO:0001965~G-protein alpha-subunit binding",0.0238095238095238,56.4900579260545,50.6282051282051,0.0195786689500341,0.0494128311596099,"440193"
"WP5355:Metabolic epileptic disorders",0.0294117647058824,66.0573209911267,49.5275919732441,2.70667307995969e-05,0.00502087856332523,"2023, 2805, 5223"
"GO:1990000~amyloid fibril formation",0.0232558139534884,54.6155072096605,48.9950372208437,0.0202251552449181,0.0503592791668766,"2280"
"R-HSA-4641262~Disassembly of the destruction complex and recruitment of AXIN to the membrane",0.0232558139534884,54.6155072096605,48.9950372208437,0.0202251552449181,0.0503592791668766,"1452"
"R-HSA-2871796~FCERI mediated MAPK activation",0.0232558139534884,54.6155072096605,48.9950372208437,0.0202251552449181,0.0503592791668766,"3265"
"WP5122:Prostaglandin and leukotriene metabolism in senescence ",0.0232558139534884,54.6155072096605,48.9950372208437,0.0202251552449181,0.0503592791668766,"3265"
"GO:0032418~lysosome localization",0.0227272727272727,52.8616806240669,47.4639423076923,0.0208712480207027,0.0511104489483875,"282991"
"GO:0007026~negative regulation of microtubule depolymerization",0.0227272727272727,52.8616806240669,47.4639423076923,0.0208712480207027,0.0511104489483875,"440193"
"GO:0019082~viral protein processing",0.0227272727272727,52.8616806240669,47.4639423076923,0.0208712480207027,0.0511104489483875,"1452"
"R-HSA-442742~CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling",0.0227272727272727,52.8616806240669,47.4639423076923,0.0208712480207027,0.0511104489483875,"3265"
"WP3844:PI3K AKT mTOR signaling and therapeutic opportunities in prostate cancer",0.0227272727272727,52.8616806240669,47.4639423076923,0.0208712480207027,0.0511104489483875,"3265"
"GO:0001578~microtubule bundle formation",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969739,0.051668527646455,"440193"
"R-HSA-187687~Signalling to ERKs",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969739,0.051668527646455,"3265"
"WP422:MAPK cascade",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969739,0.051668527646455,"3265"
"WP3676:BDNF TrkB signaling",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969739,0.051668527646455,"3265"
"WP244:Alpha 6 beta 4 signaling",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969739,0.051668527646455,"3265"
"hsa01210_2-Oxocarboxylic_acid_metabolism",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969739,0.051668527646455,"2805"
"hsa00010_Glycolysis_/_Gluconeogenesis",0.0256410256410256,54.8470718345726,45.3386911595867,0.000863647645605813,0.0249774637888529,"2023, 5223"
"GO:0060071~Wnt signaling pathway, planar cell polarity pathway",0.0217391304347826,49.5798033925979,44.6719457013575,0.0221622538932068,0.052204420281776,"440193"
"GO:0043495~protein-membrane adaptor activity",0.0217391304347826,49.5798033925979,44.6719457013575,0.0221622538932068,0.052204420281776,"3265"
"R-HSA-4791275~Signaling by WNT in cancer",0.0217391304347826,49.5798033925979,44.6719457013575,0.0221622538932068,0.052204420281776,"1452"
"WP313:Hepatocyte growth factor receptor signaling",0.0217391304347826,49.5798033925979,44.6719457013575,0.0221622538932068,0.052204420281776,"3265"
"WP5358:JAK STAT signaling in the regulation of beta cells",0.0217391304347826,49.5798033925979,44.6719457013575,0.0221622538932068,0.052204420281776,"3265"
"WP5321:Prostaglandin and leukotriene metabolism in senescence ",0.0217391304347826,49.5798033925979,44.6719457013575,0.0221622538932068,0.052204420281776,"3265"
"GO:0043015~gamma-tubulin binding",0.0212765957446809,48.1266663315149,43.3956043956044,0.0228071674287647,0.0532167240004509,"282991"
"WP400:p38 MAPK signaling",0.0212765957446809,48.1266663315149,43.3956043956044,0.0228071674287647,0.0532167240004509,"3265"
"WP4844:Influence of laminopathies on Wnt signaling",0.0212765957446809,48.1266663315149,43.3956043956044,0.0228071674287647,0.0532167240004509,"1452"
"R-HSA-1168372~Downstream signaling events of B Cell Receptor (BCR)",0.024390243902439,51.669907137314,42.7843986998917,0.000969235344891659,0.0249774637888529,"2280, 3265"
"hsa05230_Central_carbon_metabolism_in_cancer",0.024390243902439,51.669907137314,42.7843986998917,0.000969235344891659,0.0249774637888529,"3265, 5223"
"GO:0060612~adipose tissue development",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"3265"
"GO:0043122~regulation of canonical NF-kappaB signal transduction",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"54469"
"GO:0050776~regulation of immune response",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"2280"
"R-HSA-5673000~RAF activation",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"3265"
"R-HSA-6802948~Signaling by high-kinase activity BRAF mutants",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"3265"
"WP1471:Target of rapamycin signaling",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"2280"
"hsa00350_Tyrosine_metabolism",0.0208333333333333,46.7577383611577,42.1901709401709,0.0234516883229008,0.0535420084172073,"2805"
"WP4674:Head and neck squamous cell carcinoma",0.0238095238095238,50.2166113735936,41.6122233930453,0.00102424940242977,0.0249774637888529,"2280, 3265"
"GO:0031593~polyubiquitin modification-dependent protein binding",0.0204081632653061,45.4654020213576,41.049896049896,0.024095816794757,0.0540153959568269,"54469"
"GO:0051020~GTPase binding",0.0204081632653061,45.4654020213576,41.049896049896,0.024095816794757,0.0540153959568269,"2023"
"R-HSA-9735869~SARS-CoV-1 modulates host translation machinery",0.0204081632653061,45.4654020213576,41.049896049896,0.024095816794757,0.0540153959568269,"6208"
"WP49:IL2 signaling",0.0204081632653061,45.4654020213576,41.049896049896,0.024095816794757,0.0540153959568269,"3265"
"hsa00250_Alanine,_aspartate_and_glutamate_metabolism",0.0204081632653061,45.4654020213576,41.049896049896,0.024095816794757,0.0540153959568269,"2805"
"hsa05216_Thyroid_cancer",0.0204081632653061,45.4654020213576,41.049896049896,0.024095816794757,0.0540153959568269,"3265"
"GO:0005109~frizzled binding",0.02,44.2750848093294,39.9696356275304,0.0247395530633615,0.0544710634214072,"440193"
"R-HSA-70171~Glycolysis",0.0229885057471264,48.1917013064113,39.9696356275304,0.00110953624012217,0.0249774637888529,"2023, 5223"
"R-HSA-5655302~Signaling by FGFR1 in disease",0.02,44.2750848093294,39.9696356275304,0.0247395530633615,0.0544710634214072,"3265"
"R-HSA-5654741~Signaling by FGFR3",0.02,44.2750848093294,39.9696356275304,0.0247395530633615,0.0544710634214072,"3265"
"R-HSA-9607240~FLT3 Signaling",0.02,44.2750848093294,39.9696356275304,0.0247395530633615,0.0544710634214072,"3265"
"WP5215:Targeted agents in triple negative breast cancer",0.02,44.2750848093294,39.9696356275304,0.0247395530633615,0.0544710634214072,"3265"
"WP5497:Cyclin dependent kinase 4 6 inhibitors in breast cancer",0.02,44.2750848093294,39.9696356275304,0.0247395530633615,0.0544710634214072,"3265"
"hsa01200_Carbon_metabolism",0.0238095238095238,52.0602969049193,39.2805039787798,5.41325275005435e-05,0.00803326708108066,"2023, 2805, 5223"
"GO:0003755~peptidyl-prolyl cis-trans isomerase activity",0.0196078431372549,43.094166009635,38.9447731755424,0.0253828973476351,0.0553944406821919,"2280"
"R-HSA-5654743~Signaling by FGFR4",0.0196078431372549,43.094166009635,38.9447731755424,0.0253828973476351,0.0553944406821919,"3265"
"WP4871:Kisspeptin kisspeptin receptor system in the ovary",0.0196078431372549,43.094166009635,38.9447731755424,0.0253828973476351,0.0553944406821919,"3265"
"GO:0140840~RNA polymerase II CTD heptapeptide repeat P6 isomerase activity",0.0192307692307692,41.9847387011726,37.9711538461538,0.026025849866385,0.0558126606961205,"2280"
"GO:0140839~RNA polymerase II CTD heptapeptide repeat P3 isomerase activity",0.0192307692307692,41.9847387011726,37.9711538461538,0.026025849866385,0.0558126606961205,"2280"
"R-HSA-5674135~MAP2K and MAPK activation",0.0192307692307692,41.9847387011726,37.9711538461538,0.026025849866385,0.0558126606961205,"3265"
"WP2526:PDGF pathway",0.0192307692307692,41.9847387011726,37.9711538461538,0.026025849866385,0.0558126606961205,"3265"
"WP2828:Bladder cancer",0.0192307692307692,41.9847387011726,37.9711538461538,0.026025849866385,0.0558126606961205,"3265"
"hsa00260_Glycine,_serine_and_threonine_metabolism",0.0192307692307692,41.9847387011726,37.9711538461538,0.026025849866385,0.0558126606961205,"5223"
"GO:0048144~fibroblast proliferation",0.0188679245283019,40.9948384063393,37.0450281425891,0.0266684108383073,0.0565370309772115,"3265"
"KW-0697~Rotamase",0.0188679245283019,40.9948384063393,37.0450281425891,0.0266684108383073,0.0565370309772115,"2280"
"hsa05219_Bladder_cancer",0.0188679245283019,40.9948384063393,37.0450281425891,0.0266684108383073,0.0565370309772115,"3265"
"GO:0032092~positive regulation of protein binding",0.0185185185185185,39.971189432673,36.1630036630037,0.0273105804819889,0.057082959767988,"2280"
"R-HSA-1433557~Signaling by SCF-KIT",0.0185185185185185,39.971189432673,36.1630036630037,0.0273105804819889,0.057082959767988,"3265"
"R-HSA-3928662~EPHB-mediated forward signaling",0.0185185185185185,39.971189432673,36.1630036630037,0.0273105804819889,0.057082959767988,"3265"
"R-HSA-165159~MTOR signalling",0.0185185185185185,39.971189432673,36.1630036630037,0.0273105804819889,0.057082959767988,"2280"
"WP5220:Metabolic reprogramming in pancreatic cancer",0.0185185185185185,39.971189432673,36.1630036630037,0.0273105804819889,0.057082959767988,"2805"
"GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159043,0.0574533251795042,"282991"
"R-HSA-5675221~Negative regulation of MAPK pathway",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159043,0.0574533251795042,"3265"
"R-HSA-9656223~Signaling by RAF1 mutants",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159043,0.0574533251795042,"3265"
"R-HSA-5655253~Signaling by FGFR2 in disease",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159043,0.0574533251795042,"3265"
"R-HSA-9692916~SARS-CoV-1 activates/modulates innate immune responses",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159043,0.0574533251795042,"2280"
"WP4249:Hedgehog signaling",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159043,0.0574533251795042,"1452"
"R-HSA-70326~Glucose metabolism",0.0204081632653061,41.9559748141797,34.9160035366932,0.00145047681054955,0.0249774637888529,"2023, 5223"
"WP2332:IL11 signaling",0.0178571428571429,38.0949270111986,34.5192307692308,0.0285937466584176,0.0586092818247124,"3265"
"WP477:Cytoplasmic ribosomal proteins",0.0202020202020202,41.4423190410928,34.5192307692308,0.00148365794949133,0.0249774637888529,"23521, 6208"
"GO:0043406~positive regulation of MAP kinase activity",0.0175438596491228,37.2266262311026,33.7521367521367,0.0292347436277811,0.059430629511818,"3265"
"GO:0005246~calcium channel regulator activity",0.0175438596491228,37.2266262311026,33.7521367521367,0.0292347436277811,0.059430629511818,"2280"
"R-HSA-192823~Viral mRNA Translation",0.0198019801980198,40.5106413284324,33.7521367521367,0.00155110764290665,0.0249774637888529,"23521, 6208"
"R-HSA-156902~Peptide chain elongation",0.0198019801980198,40.5106413284324,33.7521367521367,0.00155110764290665,0.0249774637888529,"23521, 6208"
"WP5493:Effect of dasatinib on the BCR ABL signaling pathway",0.0175438596491228,37.2266262311026,33.7521367521367,0.0292347436277811,0.059430629511818,"3265"
"hsa03010_Ribosome",0.0206896551724138,44.4654881127817,33.7521367521367,8.50250177428866e-05,0.00901265188074598,"23521, 6208, 64981"
"GO:0002181~cytoplasmic translation",0.0196078431372549,40.0576776286803,33.3812341504649,0.00158537536332451,0.0249774637888529,"23521, 6208"
"GO:0097193~intrinsic apoptotic signaling pathway",0.0172413793103448,36.3982011232401,33.0183946488294,0.0298753501421385,0.0597428767368989,"3265"
"R-HSA-112399~IRS-mediated signalling",0.0172413793103448,36.3982011232401,33.0183946488294,0.0298753501421385,0.0597428767368989,"3265"
"WP2586:Aryl hydrocarbon receptor pathway",0.0172413793103448,36.3982011232401,33.0183946488294,0.0298753501421385,0.0597428767368989,"3265"
"WP4535:Envelope proteins and their potential roles in EDMD physiopathology",0.0172413793103448,36.3982011232401,33.0183946488294,0.0298753501421385,0.0597428767368989,"3265"
"GO:0031122~cytoplasmic microtubule organization",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"440193"
"GO:0003007~heart morphogenesis",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"2280"
"R-HSA-6802949~Signaling by RAS mutants",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"3265"
"R-HSA-6802955~Paradoxical activation of RAF signaling by kinase inactive BRAF",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"3265"
"R-HSA-6802946~Signaling by moderate kinase activity BRAF mutants",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"3265"
"R-HSA-9649948~Signaling downstream of RAS mutants",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"3265"
"R-HSA-156842~Eukaryotic Translation Elongation",0.019047619047619,38.7310145410195,32.315875613748,0.00169034502182718,0.0249774637888529,"23521, 6208"
"R-HSA-72764~Eukaryotic Translation Termination",0.019047619047619,38.7310145410195,32.315875613748,0.00169034502182718,0.0249774637888529,"23521, 6208"
"R-HSA-9864848~Complex IV assembly",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"192286"
"R-HSA-5610783~Degradation of GLI2 by the proteasome",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"1452"
"R-HSA-5610785~GLI3 is processed to GLI3R by the proteasome",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"1452"
"R-HSA-2408557~Selenocysteine synthesis",0.019047619047619,38.7310145410195,32.315875613748,0.00169034502182718,0.0249774637888529,"23521, 6208"
"WP363:Wnt signaling",0.0169491525423729,35.5812229977646,32.315875613748,0.0305155664195211,0.0597428767368989,"1452"
"R-HSA-2173789~TGF-beta receptor signaling activates SMADs",0.0166666666666667,34.846486509557,31.6426282051282,0.0311553926778491,0.0608350035972737,"2280"
"R-HSA-975956~Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",0.0186915887850467,37.9237321791297,31.6426282051282,0.00176212605029112,0.0249774637888529,"23521, 6208"
"GO:0046330~positive regulation of JNK cascade",0.018348623853211,37.1280131243713,30.9968602825746,0.0018353442086084,0.0249774637888529,"3265, 440193"
"GO:0051384~response to glucocorticoid",0.0163934426229508,34.1166340386309,30.9968602825746,0.0317948291349335,0.0614368833805225,"2805"
"R-HSA-5654736~Signaling by FGFR1",0.0163934426229508,34.1166340386309,30.9968602825746,0.0317948291349335,0.0614368833805225,"3265"
"WP286:IL3 signaling",0.0163934426229508,34.1166340386309,30.9968602825746,0.0317948291349335,0.0614368833805225,"3265"
"WP5475:Hallmark of cancer sustaining proliferative signaling",0.018348623853211,37.1280131243713,30.9968602825746,0.0018353442086084,0.0249774637888529,"1452, 3265"
"GO:0001222~transcription corepressor binding",0.0161290322580645,33.3958062145076,30.3769230769231,0.0324338760084735,0.0618661593786306,"2023"
"R-HSA-983705~Signaling by the B Cell Receptor (BCR)",0.018018018018018,36.3457875248973,30.3769230769231,0.00190999618106656,0.0249774637888529,"2280, 3265"
"R-HSA-9692914~SARS-CoV-1-host interactions",0.018018018018018,36.3457875248973,30.3769230769231,0.00190999618106656,0.0249774637888529,"2280, 6208"
"R-HSA-1227986~Signaling by ERBB2",0.0161290322580645,33.3958062145076,30.3769230769231,0.0324338760084735,0.0618661593786306,"3265"
"R-HSA-2428924~IGF1R signaling cascade",0.0161290322580645,33.3958062145076,30.3769230769231,0.0324338760084735,0.0618661593786306,"3265"
"R-HSA-2428928~IRS-related events triggered by IGF1R",0.0161290322580645,33.3958062145076,30.3769230769231,0.0324338760084735,0.0618661593786306,"3265"
"hsa00330_Arginine_and_proline_metabolism",0.0161290322580645,33.3958062145076,30.3769230769231,0.0324338760084735,0.0618661593786306,"2805"
"GO:0048146~positive regulation of fibroblast proliferation",0.0158730158730159,32.7554255340256,29.7812971342383,0.0330725335160587,0.062126126250419,"3265"
"R-HSA-2172127~DAP12 interactions",0.0158730158730159,32.7554255340256,29.7812971342383,0.0330725335160587,0.062126126250419,"3265"
"R-HSA-9633012~Response of EIF2AK4 (GCN2) to amino acid deficiency",0.0176991150442478,35.6579959542296,29.7812971342383,0.00198607865706512,0.0249774637888529,"23521, 6208"
"R-HSA-2404192~Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.0158730158730159,32.7554255340256,29.7812971342383,0.0330725335160587,0.062126126250419,"3265"
"R-HSA-72689~Formation of a pool of free 40S subunits",0.0176991150442478,35.6579959542296,29.7812971342383,0.00198607865706512,0.0249774637888529,"23521, 6208"
"R-HSA-9754678~SARS-CoV-2 modulates host translation machinery",0.0158730158730159,32.7554255340256,29.7812971342383,0.0330725335160587,0.062126126250419,"6208"
"WP4539:Synaptic signaling associated with autism spectrum disorder",0.0158730158730159,32.7554255340256,29.7812971342383,0.0330725335160587,0.062126126250419,"3265"
"R-HSA-72695~Formation of the ternary complex, and subsequently, the 43S complex",0.015625,32.1127207701065,29.2085798816568,0.0337108018751678,0.0628477763602375,"6208"
"R-HSA-74751~Insulin receptor signalling cascade",0.015625,32.1127207701065,29.2085798816568,0.0337108018751678,0.0628477763602375,"3265"
"hsa00270_Cysteine_and_methionine_metabolism",0.015625,32.1127207701065,29.2085798816568,0.0337108018751678,0.0628477763602375,"2805"
"R-HSA-177929~Signaling by EGFR",0.0153846153846154,31.4949126938842,28.6574746008708,0.0343486813031687,0.0637168038173779,"3265"
"WP304:Kit receptor signaling",0.0153846153846154,31.4949126938842,28.6574746008708,0.0343486813031687,0.0637168038173779,"3265"
"GO:0003735~structural constituent of ribosome",0.0175438596491228,37.1144010547839,28.3014811275681,0.000143317671196507,0.0118157457808676,"23521, 6208, 64981"
"GO:0031648~protein destabilization",0.0151515151515152,30.9006350159114,28.1267806267806,0.0349861720173196,0.0644162273867274,"440193"
"R-HSA-8848021~Signaling by PTK6",0.0151515151515152,30.9006350159114,28.1267806267806,0.0349861720173196,0.0644162273867274,"3265"
"R-HSA-9006927~Signaling by Non-Receptor Tyrosine Kinases",0.0151515151515152,30.9006350159114,28.1267806267806,0.0349861720173196,0.0644162273867274,"3265"
"GO:1904263~positive regulation of TORC1 signaling",0.0149253731343284,30.3286004877664,27.6153846153846,0.0356232742347675,0.0651046046359544,"1452"
"R-HSA-5658442~Regulation of RAS by GAPs",0.0149253731343284,30.3286004877664,27.6153846153846,0.0356232742347675,0.0651046046359544,"3265"
"WP4879:Overlap between signal transduction pathways contributing to LMNA laminopathies",0.0149253731343284,30.3286004877664,27.6153846153846,0.0356232742347675,0.0651046046359544,"1452"
"GO:0030170~pyridoxal phosphate binding",0.0147058823529412,29.7775948810205,27.1222527472527,0.0362599881725505,0.0656217346927621,"2805"
"GO:0003925~G protein activity",0.0147058823529412,29.7775948810205,27.1222527472527,0.0362599881725505,0.0656217346927621,"3265"
"R-HSA-156827~L13a-mediated translational silencing of Ceruloplasmin expression",0.016260162601626,32.3923245733901,27.1222527472527,0.00238783307619375,0.0284523771565878,"23521, 6208"
"WP2374:Oncostatin M signaling",0.0147058823529412,29.7775948810205,27.1222527472527,0.0362599881725505,0.0656217346927621,"3265"
"hsa04340_Hedgehog_signaling_pathway",0.0147058823529412,29.7775948810205,27.1222527472527,0.0362599881725505,0.0656217346927621,"1452"
"R-HSA-1799339~SRP-dependent cotranslational protein targeting to membrane",0.0161290322580645,32.0997415773255,26.8822328114364,0.00242995506768754,0.0284523771565878,"23521, 6208"
"R-HSA-72706~GTP hydrolysis and joining of the 60S ribosomal subunit",0.0161290322580645,32.0997415773255,26.8822328114364,0.00242995506768754,0.0284523771565878,"23521, 6208"
"R-HSA-9694635~Translation of Structural Proteins",0.0142857142857143,28.7341590377838,26.1870026525199,0.0375322520767191,0.0672679493742163,"1452"
"R-HSA-186797~Signaling by PDGF",0.0142857142857143,28.7341590377838,26.1870026525199,0.0375322520767191,0.0672679493742163,"3265"
"R-HSA-1236394~Signaling by ERBB4",0.0142857142857143,28.7341590377838,26.1870026525199,0.0375322520767191,0.0672679493742163,"3265"
"R-HSA-975957~Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",0.015748031496063,31.2529651822673,26.1870026525199,0.00255843306836046,0.0284523771565878,"23521, 6208"
"R-HSA-927802~Nonsense-Mediated Decay (NMD)",0.015748031496063,31.2529651822673,26.1870026525199,0.00255843306836046,0.0284523771565878,"23521, 6208"
"WP2032:Thyroid stimulating hormone TSH signaling",0.0142857142857143,28.7341590377838,26.1870026525199,0.0375322520767191,0.0672679493742163,"3265"
"GO:0030218~erythrocyte differentiation",0.0140845070422535,28.2396391846885,25.7431551499348,0.0381678024766277,0.0674297843753755,"6208"
"GO:0090398~cellular senescence",0.0140845070422535,28.2396391846885,25.7431551499348,0.0381678024766277,0.0674297843753755,"3265"
"R-HSA-72649~Translation initiation complex formation",0.0140845070422535,28.2396391846885,25.7431551499348,0.0381678024766277,0.0674297843753755,"6208"
"R-HSA-72702~Ribosomal scanning and start codon recognition",0.0140845070422535,28.2396391846885,25.7431551499348,0.0381678024766277,0.0674297843753755,"6208"
"R-HSA-2408522~Selenoamino acid metabolism",0.0155038759689922,30.7128894020423,25.7431551499348,0.00264584100243202,0.0284523771565878,"23521, 6208"
"WP4205:MET in type 1 papillary renal cell carcinoma",0.0140845070422535,28.2396391846885,25.7431551499348,0.0381678024766277,0.0674297843753755,"3265"
"hsa05213_Endometrial_cancer",0.0140845070422535,28.2396391846885,25.7431551499348,0.0381678024766277,0.0674297843753755,"3265"
"R-HSA-72662~Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.0138888888888889,27.7619649179679,25.3141025641026,0.038802965463918,0.0679051895618566,"6208"
"R-HSA-72737~Cap-dependent Translation Initiation",0.0152671755725191,30.1911713994303,25.3141025641026,0.00273464987364456,0.0285790169893559,"23521, 6208"
"R-HSA-72613~Eukaryotic Translation Initiation",0.0152671755725191,30.1911713994303,25.3141025641026,0.00273464987364456,0.0285790169893559,"23521, 6208"
"hsa04370_VEGF_signaling_pathway",0.0138888888888889,27.7619649179679,25.3141025641026,0.038802965463918,0.0679051895618566,"3265"
"hsa04730_Long-term_depression",0.0138888888888889,27.7619649179679,25.3141025641026,0.038802965463918,0.0679051895618566,"3265"
"R-HSA-375165~NCAM signaling for neurite out-growth",0.0136986301369863,27.3002479826094,24.8991172761665,0.0394377412550777,0.068692028195464,"3265"
"R-HSA-6790901~rRNA modification in the nucleus and cytosol",0.0136986301369863,27.3002479826094,24.8991172761665,0.0394377412550777,0.068692028195464,"6208"
"KW-0689~Ribosomal protein",0.0153061224489796,32.0151692672459,24.4975186104218,0.000219443809848234,0.0158648830632897,"23521, 6208, 64981"
"WP5180:DYRK1A involvement regarding cell proliferation in brain development",0.0135135135135135,26.8536583246626,24.4975186104218,0.0400721300664819,0.0694708423115177,"1452"
"hsa04213_Longevity_regulating_pathway",0.0135135135135135,26.8536583246626,24.4975186104218,0.0400721300664819,0.0694708423115177,"3265"
"R-HSA-9033241~Peroxisomal protein import",0.0133333333333333,26.4214212452596,24.1086691086691,0.0407061321143984,0.0699165509927862,"54469"
"R-HSA-1226099~Signaling by FGFR in disease",0.0133333333333333,26.4214212452596,24.1086691086691,0.0407061321143984,0.0699165509927862,"3265"
"WP4155:Endometrial cancer",0.0133333333333333,26.4214212452596,24.1086691086691,0.0407061321143984,0.0699165509927862,"3265"
"GO:0016197~endosomal transport",0.0131578947368421,26.0028143765458,23.7319711538462,0.0413397476149832,0.0705434711901565,"282991"
"GO:0042552~myelination",0.0131578947368421,26.0028143765458,23.7319711538462,0.0413397476149832,0.0705434711901565,"3265"
"WP3651:Pathways affected in adenoid cystic carcinoma",0.012987012987013,25.5888405090976,23.3668639053254,0.0419729767842835,0.0712676173316667,"3265"
"hsa04929_GnRH_secretion",0.012987012987013,25.5888405090976,23.3668639053254,0.0419729767842835,0.0712676173316667,"3265"
"KW-0679~Respiratory chain",0.0128205128205128,25.1942158381661,23.0128205128205,0.0426058198382375,0.0721769824656901,"192286"
"R-HSA-6802952~Signaling by BRAF and RAF1 fusions",0.0126582278481013,24.8118878496971,22.6693455797933,0.0432382769926709,0.0729154580194587,"3265"
"hsa04720_Long-term_potentiation",0.0126582278481013,24.8118878496971,22.6693455797933,0.0432382769926709,0.0729154580194587,"3265"
"WP3303:RAC1 PAK1 p38 MMP2 pathway",0.0125,24.4412584411701,22.3359728506787,0.0438703484633027,0.0734803579227328,"3265"
"WP4685:Melanoma",0.0125,24.4412584411701,22.3359728506787,0.0438703484633027,0.0734803579227328,"3265"
"hsa05221_Acute_myeloid_leukemia",0.0125,24.4412584411701,22.3359728506787,0.0438703484633027,0.0734803579227328,"3265"
"GO:0006412~translation",0.013953488372093,28.9601470529608,22.2270168855535,0.000292116849147854,0.0179911387102085,"23521, 6208, 64981"
"R-HSA-168273~Influenza Viral RNA Transcription and Replication",0.0135135135135135,26.3457125057643,22.1729365524986,0.00354562879614733,0.0320836166675771,"23521, 6208"
"WP5293:Acute myeloid leukemia",0.0123456790123457,24.0817638301696,22.0122630992196,0.0445020344657409,0.0742033923001791,"3265"
"hsa04664_Fc_epsilon_RI_signaling_pathway",0.0123456790123457,24.0817638301696,22.0122630992196,0.0445020344657409,0.0742033923001791,"3265"
"GO:0050679~positive regulation of epithelial cell proliferation",0.0121951219512195,23.7328735591176,21.6978021978022,0.045133335215484,0.0744198549553092,"3265"
"GO:0042110~T cell activation",0.0121951219512195,23.7328735591176,21.6978021978022,0.045133335215484,0.0744198549553092,"2280"
"R-HSA-5654738~Signaling by FGFR2",0.0121951219512195,23.7328735591176,21.6978021978022,0.045133335215484,0.0744198549553092,"3265"
"R-HSA-195253~Degradation of beta-catenin by the destruction complex",0.0121951219512195,23.7328735591176,21.6978021978022,0.045133335215484,0.0744198549553092,"1452"
"hsa05211_Renal_cell_carcinoma",0.0121951219512195,23.7328735591176,21.6978021978022,0.045133335215484,0.0744198549553092,"3265"
"GO:0090090~negative regulation of canonical Wnt signaling pathway",0.0131578947368421,25.5852002750911,21.543917075832,0.00375090755842879,0.0323026139665964,"1452, 440193"
"R-HSA-9772573~Late SARS-CoV-2 Infection Events",0.0120481927710843,23.3940892465886,21.3921993499458,0.0457642509279212,0.0749604286722242,"1452"
"WP2034:Leptin signaling",0.0120481927710843,23.3940892465886,21.3921993499458,0.0457642509279212,0.0749604286722242,"3265"
"hsa04917_Prolactin_signaling_pathway",0.0120481927710843,23.3940892465886,21.3921993499458,0.0457642509279212,0.0749604286722242,"3265"
"R-HSA-5632684~Hedgehog 'on' state",0.0119047619047619,23.0649431582636,21.0950854700855,0.0463947818183318,0.0754932633973732,"1452"
"WP4255:Non small cell lung cancer",0.0119047619047619,23.0649431582636,21.0950854700855,0.0463947818183318,0.0754932633973732,"3265"
"WP5289:Axon guidance",0.0119047619047619,23.0649431582636,21.0950854700855,0.0463947818183318,0.0754932633973732,"3265"
"R-HSA-9678108~SARS-CoV-1 Infection",0.0128205128205128,24.867504768565,20.9496021220159,0.00396164133552597,0.0323026139665964,"2280, 6208"
"WP4216:Chromosomal and microsatellite instability in colorectal cancer ",0.0117647058823529,22.7449966597369,20.8061116965227,0.0470249281018862,0.0760185112235284,"1452"
"hsa05218_Melanoma",0.0117647058823529,22.7449966597369,20.8061116965227,0.0470249281018862,0.0760185112235284,"3265"
"hsa05223_Non-small_cell_lung_cancer",0.0117647058823529,22.7449966597369,20.8061116965227,0.0470249281018862,0.0760185112235284,"3265"
"R-HSA-9824439~Bacterial Infection Pathways",0.0116279069767442,22.4220120756868,20.524948024948,0.0476546899936446,0.0767023426795755,"2023"
"WP2037:Prolactin signaling",0.0116279069767442,22.4220120756868,20.524948024948,0.0476546899936446,0.0767023426795755,"3265"
"hsa05224_Breast_cancer",0.0125786163522013,24.3563542344307,20.524948024948,0.0041232561201999,0.0332549569694383,"1452, 3265"
"hsa05226_Gastric_cancer",0.0125,24.1915647779954,20.3871966959215,0.00417780452971219,0.0333274499442141,"1452, 3265"
"GO:0019003~GDP binding",0.0114942528735632,22.1182496407348,20.2512820512821,0.0482840677085586,0.0772128841373933,"3265"
"WP5356:Affected pathways in Duchenne muscular dystrophy",0.0114942528735632,22.1182496407348,20.2512820512821,0.0482840677085586,0.0772128841373933,"2280"
"WP69:T cell receptor signaling",0.0114942528735632,22.1182496407348,20.2512820512821,0.0482840677085586,0.0772128841373933,"3265"
"GO:0042274~ribosomal small subunit biogenesis",0.0113636363636364,21.8100527091348,19.9848178137652,0.0489130614614717,0.0773848435062089,"6208"
"GO:0018105~peptidyl-serine phosphorylation",0.0113636363636364,21.8100527091348,19.9848178137652,0.0489130614614717,0.0773848435062089,"1452"
"R-HSA-9009391~Extra-nuclear estrogen signaling",0.0113636363636364,21.8100527091348,19.9848178137652,0.0489130614614717,0.0773848435062089,"3265"
"WP4341:Non genomic actions of 1 25 dihydroxyvitamin D3",0.0113636363636364,21.8100527091348,19.9848178137652,0.0489130614614717,0.0773848435062089,"3265"
"hsa05214_Glioma",0.0113636363636364,21.8100527091348,19.9848178137652,0.0489130614614717,0.0773848435062089,"3265"
"GO:0071346~cellular response to type II interferon",0.0112359550561798,21.5258556616482,19.7252747252747,0.0495416714671152,0.0780465397634808,"23521"
"hsa05220_Chronic_myeloid_leukemia",0.0112359550561798,21.5258556616482,19.7252747252747,0.0495416714671152,0.0780465397634808,"3265"
"WP4262:Breast cancer pathway",0.0120481927710843,23.2425744902174,19.5980148883375,0.00451217367850198,0.0333274499442141,"1452, 3265"
"GO:0032729~positive regulation of type II interferon production",0.0111111111111111,21.2477988667627,19.4723865877712,0.0501698979401132,0.0787020386290993,"3265"
"hsa03018_RNA_degradation",0.0111111111111111,21.2477988667627,19.4723865877712,0.0501698979401132,0.0787020386290993,"2023"
"R-HSA-9711097~Cellular response to starvation",0.0119047619047619,22.9413971064337,19.3483586477217,0.00462631717554455,0.0333274499442141,"23521, 6208"
"R-HSA-611105~Respiratory electron transport",0.0119047619047619,22.9413971064337,19.3483586477217,0.00462631717554455,0.0333274499442141,"192286, 2805"
"R-HSA-168255~Influenza Infection",0.0118343195266272,22.7925504749893,19.2259006815969,0.00468389097449502,0.0334177606064933,"23521, 6208"
"R-HSA-6806834~Signaling by MET",0.010989010989011,20.9760508408138,19.2259006815969,0.0507977410949805,0.0795188267773745,"3265"
"R-HSA-9010553~Regulation of expression of SLITs and ROBOs",0.0117647058823529,22.6420032962212,19.1049830672472,0.00474179894632483,0.0335087125540288,"23521, 6208"
"GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process",0.0108695652173913,20.7106451782309,18.9855769230769,0.0514252011461227,0.0799947573384131,"1452"
"R-HSA-74752~Signaling by Insulin receptor",0.0108695652173913,20.7106451782309,18.9855769230769,0.0514252011461227,0.0799947573384131,"3265"
"hsa01521_EGFR_tyrosine_kinase_inhibitor_resistance",0.0108695652173913,20.7106451782309,18.9855769230769,0.0514252011461227,0.0799947573384131,"3265"
"GO:0007265~Ras protein signal transduction",0.010752688172043,20.4510827811989,18.7511870845204,0.0520522783078365,0.0808008169548425,"3265"
"WP2261:Glioblastoma signaling",0.0106382978723404,20.190671188866,18.5225140712946,0.0526789727943094,0.0816029181907675,"3265"
"GO:0030165~PDZ domain binding",0.0104166666666667,19.7179385327458,18.0815018315018,0.0539312145977375,0.083022741144235,"440193"
"R-HSA-6802957~Oncogenic MAPK signaling",0.0104166666666667,19.7179385327458,18.0815018315018,0.0539312145977375,0.083022741144235,"3265"
"KW-0413~Isomerase",0.0111731843575419,21.415991370892,18.0815018315018,0.00527794337074663,0.0349663748311964,"2280, 5223"
"WP4806:EGFR tyrosine kinase inhibitor resistance",0.0104166666666667,19.7179385327458,18.0815018315018,0.0539312145977375,0.083022741144235,"3265"
"hsa05225_Hepatocellular_carcinoma",0.0111111111111111,21.2859451205085,17.9745106964042,0.00533917138772181,0.0350589838025627,"1452, 3265"
"R-HSA-190236~Signaling by FGFR",0.0103092783505155,19.4798708497844,17.868778280543,0.0545567623425223,0.0834662219755701,"3265"
"WP4018:Clear cell renal cell carcinoma pathways",0.0103092783505155,19.4798708497844,17.868778280543,0.0545567623425223,0.0834662219755701,"2023"
"WP2571:Polycystic kidney disease pathway",0.0103092783505155,19.4798708497844,17.868778280543,0.0545567623425223,0.0834662219755701,"3265"
"WP4336:ncRNAs in Wnt signaling in hepatocellular carcinoma",0.0102040816326531,19.2482082611619,17.6610017889088,0.0551819282677286,0.0840759564161286,"1452"
"hsa04012_ErbB_signaling_pathway",0.0102040816326531,19.2482082611619,17.6610017889088,0.0551819282677286,0.0840759564161286,"3265"
"GO:0043547~positive regulation of GTPase activity",0.0101010101010101,19.0225024310901,17.4580017683466,0.055806712586998,0.0843351949889053,"3265"
"R-HSA-438064~Post NMDA receptor activation events",0.0101010101010101,19.0225024310901,17.4580017683466,0.055806712586998,0.0843351949889053,"3265"
"hsa04310_Wnt_signaling_pathway",0.0108108108108108,20.6600855133551,17.4580017683466,0.00565025128477659,0.0356592155948108,"1452, 440193"
"hsa04662_B_cell_receptor_signaling_pathway",0.0101010101010101,19.0225024310901,17.4580017683466,0.055806712586998,0.0843351949889053,"3265"
"hsa05210_Colorectal_cancer",0.0101010101010101,19.0225024310901,17.4580017683466,0.055806712586998,0.0843351949889053,"3265"
"R-HSA-5389840~Mitochondrial translation elongation",0.01,18.8023800461217,17.2596153846154,0.0564311155138658,0.084589672144017,"64981"
"R-HSA-5419276~Mitochondrial translation termination",0.01,18.8023800461217,17.2596153846154,0.0564311155138658,0.084589672144017,"64981"
"R-HSA-5368286~Mitochondrial translation initiation",0.01,18.8023800461217,17.2596153846154,0.0564311155138658,0.084589672144017,"64981"
"WP5098:T cell activation SARS CoV 2",0.01,18.8023800461217,17.2596153846154,0.0564311155138658,0.084589672144017,"3265"
"WP231:TNF alpha signaling",0.0099009900990099,18.5875269709801,17.0656871218669,0.0570551372617581,0.0853526448552914,"3265"
"GO:0051402~neuron apoptotic process",0.00980392156862745,18.3776757628204,16.8760683760684,0.0576787780439925,0.0855953066172848,"3265"
"WP673:ErbB signaling",0.00980392156862745,18.3776757628204,16.8760683760684,0.0576787780439925,0.0855953066172848,"3265"
"hsa04211_Longevity_regulating_pathway",0.00980392156862745,18.3776757628204,16.8760683760684,0.0576787780439925,0.0855953066172848,"3265"
"hsa05235_PD-L1_expression_and_PD-1_checkpoint_pathway_in_cancer",0.00980392156862745,18.3776757628204,16.8760683760684,0.0576787780439925,0.0855953066172848,"3265"
"WP35:G protein signaling",0.00970873786407767,18.1725958386702,16.6906170752325,0.0583020380737775,0.0863475294426007,"3265"
"GO:0032869~cellular response to insulin stimulus",0.00961538461538462,17.9711372064644,16.5091973244147,0.0589249175642144,0.0864076854400139,"2805"
"R-HSA-2682334~EPH-Ephrin signaling",0.00961538461538462,17.9711372064644,16.5091973244147,0.0589249175642144,0.0864076854400139,"3265"
"WP3925:Amino acid metabolism",0.00961538461538462,17.9711372064644,16.5091973244147,0.0589249175642144,0.0864076854400139,"2805"
"WP23:B cell receptor signaling",0.00961538461538462,17.9711372064644,16.5091973244147,0.0589249175642144,0.0864076854400139,"3265"
"hsa04540_Gap_junction",0.00961538461538462,17.9711372064644,16.5091973244147,0.0589249175642144,0.0864076854400139,"3265"
"R-HSA-6791226~Major pathway of rRNA processing in the nucleolus and cytosol",0.0101522842639594,19.2897186696753,16.3316790736146,0.00643019486839957,0.0379965457149183,"23521, 6208"
"WP4746:Thyroid hormones production and peripheral downstream signaling effects",0.00952380952380952,17.7817856668274,16.3316790736146,0.0595474167282943,0.0866908651416403,"3265"
"hsa04912_GnRH_signaling_pathway",0.00952380952380952,17.7817856668274,16.3316790736146,0.0595474167282943,0.0866908651416403,"3265"
"GO:0032880~regulation of protein localization",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"2280"
"GO:0009887~animal organ morphogenesis",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"3265"
"GO:0017148~negative regulation of translation",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"23521"
"GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"2280"
"GO:0032543~mitochondrial translation",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"64981"
"R-HSA-5368287~Mitochondrial translation",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"64981"
"WP4258:lncRNA in canonical Wnt signaling and colorectal cancer",0.00943396226415094,17.57881021408,16.157937806874,0.0601695357789013,0.0866908651416403,"1452"
"WP2806:Complement system",0.00934579439252336,17.3952935548072,15.9878542510121,0.0607912749288111,0.0874169108472438,"1452"
"GO:0051604~protein maturation",0.00925925925925926,17.2123636868984,15.8213141025641,0.0614126343906907,0.0877999512868834,"2280"
"R-HSA-170834~Signaling by TGF-beta Receptor Complex",0.00925925925925926,17.2123636868984,15.8213141025641,0.0614126343906907,0.0877999512868834,"2280"
"hsa01522_Endocrine_resistance",0.00925925925925926,17.2123636868984,15.8213141025641,0.0614126343906907,0.0877999512868834,"3265"
"R-HSA-4420097~VEGFA-VEGFR2 Pathway",0.00917431192660551,17.0302284322454,15.6582077716098,0.0620336143770975,0.0885171958996276,"3265"
"R-HSA-72766~Translation",0.0099009900990099,20.0931502080265,15.5513258072985,0.000828410963079033,0.0249774637888529,"23521, 6208, 64981"
"R-HSA-8868773~rRNA processing in the nucleus and cytosol",0.00966183574879227,18.2912261487052,15.4984301412873,0.00711573117893359,0.0379965457149183,"23521, 6208"
"KW-0879~Wnt signaling pathway",0.00966183574879227,18.2912261487052,15.4984301412873,0.00711573117893359,0.0379965457149183,"1452, 440193"
"hsa05215_Prostate_cancer",0.00909090909090909,16.8491563670017,15.4984301412873,0.0626542151004843,0.0892311470337032,"3265"
"hsa05231_Choline_metabolism_in_cancer",0.00900900900900901,16.6864298482595,15.3418803418803,0.0632744367731922,0.089941823918982,"3265"
"R-HSA-5610787~Hedgehog 'off' state",0.00892857142857143,16.5141720021059,15.1884615384615,0.0638942796074561,0.0904762508945275,"1452"
"R-HSA-442755~Activation of NMDA receptors and postsynaptic events",0.00892857142857143,16.5141720021059,15.1884615384615,0.0638942796074561,0.0904762508945275,"3265"
"KW-0687~Ribonucleoprotein",0.00967741935483871,19.6216138494302,15.1884615384615,0.000887055923241818,0.0249774637888529,"23521, 6208, 64981"
"R-HSA-9679191~Potential therapeutics for SARS",0.00884955752212389,16.3483556037224,15.03808073115,0.0645137438154028,0.0906613596799789,"2280"
"WP185:Integrin mediated cell adhesion",0.00884955752212389,16.3483556037224,15.03808073115,0.0645137438154028,0.0906613596799789,"3265"
"hsa04916_Melanogenesis",0.00884955752212389,16.3483556037224,15.03808073115,0.0645137438154028,0.0906613596799789,"3265"
"hsa04933_AGE-RAGE_signaling_pathway_in_diabetic_complications",0.00884955752212389,16.3483556037224,15.03808073115,0.0645137438154028,0.0906613596799789,"3265"
"GO:0032956~regulation of actin cytoskeleton organization",0.0087719298245614,16.1858400506689,14.8906485671192,0.0651328296090492,0.0911859614526689,"3265"
"GO:0071356~cellular response to tumor necrosis factor",0.00869565217391304,16.0265327542887,14.7460791635549,0.0657515372003074,0.0917060913583234,"54469"
"R-HSA-72312~rRNA processing",0.00921658986175115,17.3925002948416,14.7460791635549,0.00783320485166757,0.0383448821627303,"23521, 6208"
"R-HSA-376176~Signaling by ROBO receptors",0.00917431192660551,17.3068691604296,14.6748420661464,0.00790669403085948,0.0383448821627303,"23521, 6208"
"hsa04137_Mitophagy",0.00862068965517241,15.8703441607982,14.6042899408284,0.0663698668009792,0.0923948239518322,"3265"
"hsa04625_C-type_lectin_receptor_signaling_pathway",0.00854700854700855,15.7171874832477,14.4652014652015,0.0669878186227594,0.0930804520937967,"3265"
"hsa04922_Glucagon_signaling_pathway",0.00847457627118644,15.5669785065071,14.3287373004354,0.0676053928772355,0.0937629934858108,"5223"
"R-HSA-194138~Signaling by VEGF",0.00833333333333333,15.2750788470624,14.0633903133903,0.0688394095300821,0.0951188861663331,"3265"
"WP4321:Thermogenesis",0.00833333333333333,15.2750788470624,14.0633903133903,0.0688394095300821,0.0951188861663331,"3265"
"GO:0050852~T cell receptor signaling pathway",0.00826446280991736,15.1332315087478,13.9343683839097,0.0694558523510888,0.0952610766072234,"3265"
"KW-0249~Electron transport",0.00826446280991736,15.1332315087478,13.9343683839097,0.0694558523510888,0.0952610766072234,"192286"
"WP2263:Androgen receptor network in prostate cancer",0.00826446280991736,15.1332315087478,13.9343683839097,0.0694558523510888,0.0952610766072234,"3265"
"WP5380:5q35 copy number variation",0.00826446280991736,15.1332315087478,13.9343683839097,0.0694558523510888,0.0952610766072234,"192286"
"GO:0006417~regulation of translation",0.00819672131147541,14.994018431519,13.8076923076923,0.0700719184500622,0.0955760358271069,"6208"
"WP710:DNA damage response only ATM dependent ",0.00819672131147541,14.994018431519,13.8076923076923,0.0700719184500622,0.0955760358271069,"3265"
"hsa04066_HIF-1_signaling_pathway",0.00819672131147541,14.994018431519,13.8076923076923,0.0700719184500622,0.0955760358271069,"2023"
"R-HSA-201681~TCF dependent signaling in response to WNT",0.00858369098712446,16.1164154848869,13.6832986832987,0.00904663943743193,0.0396566842946707,"1452, 440193"
"GO:0009615~response to virus",0.00806451612903226,14.7232058203447,13.5611263736264,0.0713029213259955,0.0968988418019938,"2023"
"hsa04726_Serotonergic_synapse",0.00806451612903226,14.7232058203447,13.5611263736264,0.0713029213259955,0.0968988418019938,"3265"
"R-HSA-187037~Signaling by NTRK1 (TRKA)",0.00793650793650794,14.462083603711,13.3232118758435,0.0725324198449814,0.0982099553375478,"3265"
"WP428:Wnt signaling",0.00793650793650794,14.462083603711,13.3232118758435,0.0725324198449814,0.0982099553375478,"1452"
"WP4659:Gastrin signaling",0.0078740157480315,14.3349912711376,13.2073578595318,0.0731466054973686,0.0986814205073591,"3265"
"hsa04725_Cholinergic_synapse",0.0078740157480315,14.3349912711376,13.2073578595318,0.0731466054973686,0.0986814205073591,"3265"
"GO:0007219~Notch signaling pathway",0.00775193798449612,14.0874315996098,12.9815910585141,0.0743738506404906,0.100154985798991,"2805"
"GO:0030308~negative regulation of cell growth",0.00769230769230769,13.9668451530852,12.8715775749674,0.0749869105519273,0.100433732183267,"2023"
"GO:0008286~insulin receptor signaling pathway",0.00769230769230769,13.9668451530852,12.8715775749674,0.0749869105519273,0.100433732183267,"3265"
"R-HSA-71291~Metabolism of amino acids and derivatives",0.00824175824175824,16.5569613075686,12.8715775749674,0.00142991401690382,0.0249774637888529,"23521, 2805, 6208"
"WP3931:Embryonic stem cell pluripotency pathways",0.00769230769230769,13.9668451530852,12.8715775749674,0.0749869105519273,0.100433732183267,"3265"
"hsa05171_Coronavirus_disease",0.00809716599190283,15.1439048736603,12.8715775749674,0.0101734423584278,0.0399021652149657,"23521, 6208"
"R-HSA-2454202~Fc epsilon receptor (FCERI) signaling",0.00757575757575758,13.7317756412476,12.6570512820513,0.0762119061055019,0.101161420984405,"3265"
"WP2431:Spinal cord injury",0.00757575757575758,13.7317756412476,12.6570512820513,0.0762119061055019,0.101161420984405,"2280"
"WP5470:Effect of omega 3 PUFA on Huntington 39 s disease pathways",0.00757575757575758,13.7317756412476,12.6570512820513,0.0762119061055019,0.101161420984405,"3265"
"WP4541:Hippo Merlin signaling dysregulation",0.00757575757575758,13.7317756412476,12.6570512820513,0.0762119061055019,0.101161420984405,"3265"
"hsa04722_Neurotrophin_signaling_pathway",0.00757575757575758,13.7317756412476,12.6570512820513,0.0762119061055019,0.101161420984405,"3265"
"GO:0007264~small GTPase-mediated signal transduction",0.0075187969924812,13.6058765924698,12.5524475524476,0.0768238421676999,0.101514257584376,"440193"
"GO:0007030~Golgi organization",0.0075187969924812,13.6058765924698,12.5524475524476,0.0768238421676999,0.101514257584376,"1452"
"GO:0000165~MAPK cascade",0.00746268656716418,13.4933658507177,12.4495586380832,0.077435404033365,0.101514257584376,"3265"
"hsa04071_Sphingolipid_signaling_pathway",0.00746268656716418,13.4933658507177,12.4495586380832,0.077435404033365,0.101514257584376,"3265"
"hsa04660_T_cell_receptor_signaling_pathway",0.00746268656716418,13.4933658507177,12.4495586380832,0.077435404033365,0.101514257584376,"3265"
"hsa04919_Thyroid_hormone_signaling_pathway",0.00746268656716418,13.4933658507177,12.4495586380832,0.077435404033365,0.101514257584376,"3265"
"hsa04935_Growth_hormone_synthesis,_secretion_and_action",0.00746268656716418,13.4933658507177,12.4495586380832,0.077435404033365,0.101514257584376,"3265"
"GO:0001934~positive regulation of protein phosphorylation",0.00735294117647059,13.2738160827931,12.2487593052109,0.0786574060140415,0.102572575153636,"3265"
"GO:0031175~neuron projection development",0.00714285714285714,12.8553271453481,11.8659855769231,0.0810969288393815,0.105568282804949,"282991"
"GO:0006935~chemotaxis",0.00709219858156028,12.7558251654285,11.7740011926058,0.0817058771966783,0.105989092447439,"3265"
"R-HSA-5621481~C-type lectin receptors (CLRs)",0.00709219858156028,12.7558251654285,11.7740011926058,0.0817058771966783,0.105989092447439,"3265"
"R-HSA-1428517~Aerobic respiration and respiratory electron transport",0.00740740740740741,13.7649050606074,11.7285417285417,0.0121536104105065,0.0412686722343987,"192286, 2805"
"hsa04926_Relaxin_signaling_pathway",0.00704225352112676,12.6563572515716,11.6834319526627,0.0823144530325484,0.106511582208871,"3265"
"WP2059:Alzheimer 39 s disease and miRNA effects",0.0072992700729927,13.5568759663135,11.5501608657502,0.0125140852462799,0.0412686722343987,"1452, 3265"
"WP5124:Alzheimer 39 s disease",0.0072992700729927,13.5568759663135,11.5501608657502,0.0125140852462799,0.0412686722343987,"1452, 3265"
"WP3915:Angiopoietin like protein 8 regulatory pathway",0.00694444444444444,12.4619770190941,11.5064102564103,0.0835304879755399,0.107790647091914,"3265"
"R-HSA-166520~Signaling by NTRKs",0.00689655172413793,12.3669955710449,11.4198958935801,0.084137947500157,0.108198192452542,"3265"
"hsa04068_FoxO_signaling_pathway",0.00689655172413793,12.3669955710449,11.4198958935801,0.084137947500157,0.108198192452542,"3265"
"KW-0810~Translation regulation",0.00684931506849315,12.2734422078723,11.3346727898967,0.0847450353383425,0.108602445977634,"23521"
"hsa04650_Natural_killer_cell_mediated_cytotoxicity",0.00684931506849315,12.2734422078723,11.3346727898967,0.0847450353383425,0.108602445977634,"3265"
"GO:0070588~calcium ion transmembrane transport",0.00680272108843537,12.1812848977289,11.2507122507123,0.0853517516985791,0.109191378897148,"2280"
"R-HSA-5358351~Signaling by Hedgehog",0.00675675675675676,12.0904925571984,11.1679864253394,0.0859580967892428,0.109589188690066,"1452"
"R-HSA-202733~Cell surface interactions at the vascular wall",0.00675675675675676,12.0904925571984,11.1679864253394,0.0859580967892428,0.109589188690066,"3265"
"WP2380:Brain derived neurotrophic factor BDNF signaling",0.00671140939597315,12.0010350175765,11.0864682762493,0.0865640708186042,0.109983802307199,"3265"
"hsa04210_Apoptosis",0.00671140939597315,12.0010350175765,11.0864682762493,0.0865640708186042,0.109983802307199,"3265"
"GO:0032496~response to lipopolysaccharide",0.00666666666666667,11.912882992479,11.0061315496098,0.0871696739948262,0.110187219938946,"23521"
"WP2858:Ectoderm differentiation",0.00666666666666667,11.912882992479,11.0061315496098,0.0871696739948262,0.110187219938946,"440193"
"hsa04910_Insulin_signaling_pathway",0.00666666666666667,11.912882992479,11.0061315496098,0.0871696739948262,0.110187219938946,"3265"
"hsa04371_Apelin_signaling_pathway",0.00662251655629139,11.8260080467139,10.9269507470946,0.0877749065259663,0.110575518917261,"3265"
"hsa04915_Estrogen_signaling_pathway",0.00662251655629139,11.8260080467139,10.9269507470946,0.0877749065259663,0.110575518917261,"3265"
"R-HSA-9679506~SARS-CoV Infections",0.00699300699300699,13.9169014027258,10.8747934642923,0.00231595504643352,0.0284523771565878,"1452, 2280, 6208"
"WP5083:Neuroinflammation and glutamatergic signaling",0.00657894736842105,11.7403825663581,10.8489010989011,0.0883797686199764,0.11114879375597,"2805"
"GO:0007166~cell surface receptor signaling pathway",0.00680272108843537,12.581087760297,10.7338950801848,0.0143866333936571,0.0439477302592359,"1452, 3265"
"GO:0044325~transmembrane transporter binding",0.00649350649350649,11.572773480999,10.6960996749729,0.0895883823278814,0.112478138218761,"2280"
"hsa04550_Signaling_pathways_regulating_pluripotency_of_stem_cells",0.00641025641025641,11.409850184267,10.5475427350427,0.0907955167800328,0.113801137585784,"3265"
"R-HSA-71387~Metabolism of carbohydrates",0.0065359477124183,12.0609274596686,10.2972620599739,0.0155654706819478,0.046386750704368,"2023, 5223"
"hsa04072_Phospholipase_D_signaling_pathway",0.0062111801242236,11.0231532938009,10.1935983479608,0.0938068920547319,0.117179653038066,"3265"
"R-HSA-9694516~SARS-CoV-2 Infection",0.00645161290322581,11.8890504755157,10.1595060457937,0.0159674971449816,0.0465154164738942,"1452, 6208"
"GO:0043524~negative regulation of neuron apoptotic process",0.00617283950617284,10.9485719064599,10.125641025641,0.0944080611914586,0.117732405721113,"3265"
"WP4666:Hepatitis B infection",0.00613496932515337,10.8758083985008,10.0585838003057,0.0950088621715303,0.118282845186704,"3265"
"WP536:Calcium regulation in cardiac cells",0.00609756097560976,10.8042770353876,9.99240890688259,0.0956092952016302,0.118830983315929,"2280"
"R-HSA-5663202~Diseases of signal transduction by growth factor receptors and second messengers",0.00641025641025641,12.7036268120814,9.94877393349009,0.00298177212410578,0.0301194590522005,"1452, 2280, 3265"
"hsa04921_Oxytocin_signaling_pathway",0.00602409638554217,10.6565236135515,9.86263736263736,0.0968090582381109,0.119920402692284,"3265"
"GO:0042127~regulation of cell population proliferation",0.00598802395209581,10.5873628520344,9.79900744416874,0.0974083886573294,0.120461707306231,"3265"
"hsa04150_mTOR_signaling_pathway",0.00591715976331361,10.4514001205019,9.67417932386085,0.0986059483290216,0.121537564219492,"3265"
"hsa04218_Cellular_senescence",0.00591715976331361,10.4514001205019,9.67417932386085,0.0986059483290216,0.121537564219492,"3265"
"WP437:EGF EGFR signaling",0.00584795321637427,10.3185971117095,9.55249153362361,0.0998020411522281,0.122604494263168,"3265"
"hsa05160_Hepatitis_C",0.00584795321637427,10.3185971117095,9.55249153362361,0.0998020411522281,0.122604494263168,"3265"
"R-HSA-195721~Signaling by WNT",0.00604229607250755,11.0949639696093,9.49278846153846,0.0181514811295578,0.0479403182814604,"1452, 440193"
"R-HSA-9006936~Signaling by TGFB family members",0.00581395348837209,10.2533750066847,9.49278846153846,0.100399538010444,0.12293144753094,"2280"
"WP481:Insulin signaling",0.00581395348837209,10.2533750066847,9.49278846153846,0.100399538010444,0.12293144753094,"3265"
"WP4239:Epithelial to mesenchymal transition in colorectal cancer",0.00578034682080925,10.1889319307923,9.4338270425227,0.100996668774083,0.123458860346573,"3265"
"hsa05161_Hepatitis_B",0.00571428571428571,10.0623522748327,9.31807456347334,0.102189832840039,0.12450715265568,"3265"
"hsa05206_MicroRNAs_in_cancer",0.00571428571428571,10.0623522748327,9.31807456347334,0.102189832840039,0.12450715265568,"3265"
"GO:0006457~protein folding",0.00568181818181818,10.0001978001102,9.26125703564728,0.1027858665533,0.125028054069752,"2280"
"WP3929:Chemokine signaling",0.00564971751412429,9.93860800234893,9.2051282051282,0.10338153499387,0.125546806817434,"3265"
"R-HSA-9609507~Protein localization",0.00561797752808989,9.87688240953983,9.14967562557924,0.10397683836696,0.126063421680203,"54469"
"hsa05165_Human_papillomavirus_infection",0.00583090379008746,10.6880519861383,9.14967562557924,0.0194539397983167,0.0494128311596099,"1452, 3265"
"hsa04140_Autophagy",0.00555555555555556,9.75612856524005,9.04075091575092,0.105166350731007,0.127090280525093,"3265"
"hsa04630_JAK-STAT_signaling_pathway",0.00555555555555556,9.75612856524005,9.04075091575092,0.105166350731007,0.127090280525093,"3265"
"KW-0344~Guanine-nucleotide releasing factor",0.00552486187845304,9.70276656849806,8.98725534820209,0.105760560131859,0.127600545720064,"440193"
"KW-0456~Lyase",0.00543478260869565,9.52995267340861,8.83050089445438,0.107541003666907,0.129538027144229,"2023"
"R-HSA-422475~Axon guidance",0.00541516245487365,10.6374951798482,8.37598981900453,0.00483987525862644,0.0338791268103851,"23521, 3265, 6208"
"GO:0046983~protein dimerization activity",0.00510204081632653,8.89848873473592,8.25459866220736,0.114630105855606,0.137407978263101,"440193"
"WP4223:Ras signaling",0.00510204081632653,8.89848873473592,8.25459866220736,0.114630105855606,0.137407978263101,"3265"
"hsa04360_Axon_guidance",0.00510204081632653,8.89848873473592,8.25459866220736,0.114630105855606,0.137407978263101,"3265"
"hsa05034_Alcoholism",0.005,8.7053134068773,8.07896890343699,0.116981564522584,0.140000517541544,"3265"
"R-HSA-9675108~Nervous system development",0.00518134715025907,10.1548030821122,8.00797620657023,0.00548683944118265,0.0356592155948108,"23521, 3265, 6208"
"hsa04062_Chemokine_signaling_pathway",0.0048780487804878,8.47689314769582,7.86966919091271,0.119912780901942,0.143047079468234,"3265"
"GO:0006897~endocytosis",0.00483091787439614,8.39062156215797,7.78895463510848,0.121082750488936,0.143979809074985,"3265"
"hsa05010_Alzheimer_disease",0.00498753117206983,9.06344537214022,7.78895463510848,0.0262864275210399,0.0562090179268346,"1452, 3265"
"hsa05167_Kaposi_sarcoma-associated_herpesvirus_infection",0.00483091787439614,8.39062156215797,7.78895463510848,0.121082750488936,0.143979809074985,"3265"
"GO:0070374~positive regulation of ERK1 and ERK2 cascade",0.00476190476190476,8.26072248995181,7.67094017094017,0.122835013176215,0.145829727642802,"3265"
"WP306:Focal adhesion",0.004739336492891,8.21860233620149,7.63239273289525,0.123418383761404,0.146288244011122,"3265"
"GO:0016055~Wnt signaling pathway",0.00471698113207547,8.17690724156468,7.59423076923077,0.124001396194184,0.146511203783574,"1452"
"hsa05207_Chemical_carcinogenesis",0.00471698113207547,8.17690724156468,7.59423076923077,0.124001396194184,0.146511203783574,"3265"
"hsa05205_Proteoglycans_in_cancer",0.00469483568075117,8.13563114705533,7.55644852659778,0.124584050676121,0.146965605090114,"3265"
"GO:0043410~positive regulation of MAPK cascade",0.00465116279069767,8.05431228068708,7.48200075786283,0.125748286593236,0.147634855462312,"3265"
"R-HSA-9705683~SARS-CoV-2-host interactions",0.00465116279069767,8.05431228068708,7.48200075786283,0.125748286593236,0.147634855462312,"6208"
"hsa04510_Focal_adhesion",0.00465116279069767,8.05431228068708,7.48200075786283,0.125748286593236,0.147634855462312,"3265"
"R-HSA-5663205~Infectious disease",0.00484966052376334,11.4855063656859,7.42349048800662,0.00033551683741577,0.0179911387102085,"1452, 2023, 2280, 23521, 6208"
"hsa05203_Viral_carcinogenesis",0.00460829493087558,7.97459940417923,7.40900562851782,0.126911093123242,0.148764662081272,"3265"
"GO:0003714~transcription corepressor activity",0.0045662100456621,7.89644770109217,7.33742103307321,0.128072471874985,0.149653187608251,"2023"
"R-HSA-9824446~Viral Infection Pathways",0.00477326968973747,10.1822224461387,7.32857010299712,0.0016275644185453,0.0249774637888529,"1452, 2280, 23521, 6208"
"R-HSA-112314~Neurotransmitter receptors and postsynaptic signal transmission",0.00446428571428571,7.70761666837337,7.16436865021771,0.130969682767654,0.152558092015069,"3265"
"hsa04015_Rap1_signaling_pathway",0.00446428571428571,7.70761666837337,7.16436865021771,0.130969682767654,0.152558092015069,"3265"
"hsa05170_Human_immunodeficiency_virus_1_infection",0.00444444444444444,7.67093161663467,7.13073311664861,0.131548057524426,0.152991628029975,"3265"
"WP3888:VEGFA VEGFR2 signaling",0.00452488687782805,8.17877502327915,7.04800999464573,0.0316282965238763,0.0614368833805225,"23521, 3265"
"hsa05417_Lipid_and_atherosclerosis",0.0043859649122807,7.5629492527674,7.03169515669516,0.133281050556325,0.154764537578706,"3265"
"R-HSA-416476~G alpha (q) signalling events",0.00436681222707424,7.52763007066362,6.9992910315491,0.133858005154244,0.155191624725702,"3265"
"WP5087:Pleural mesothelioma",0.00444444444444444,8.02597322852822,6.91957245487997,0.0327177757950759,0.062126126250419,"1452, 3265"
"R-HSA-8939211~ESR-mediated signaling",0.00425531914893617,7.32247908474235,6.81096929975854,0.137312294390485,0.158948084926271,"3265"
"hsa05166_Human_T-cell_leukemia_virus_1_infection",0.00423728813559322,7.2893732789782,6.78056318681319,0.13788677139965,0.159364461648817,"3265"
"hsa05163_Human_cytomegalovirus_infection",0.00420168067226891,7.22405416698678,6.72055820285909,0.139034666184972,0.160192115387033,"3265"
"hsa05208_Chemical_carcinogenesis",0.00420168067226891,7.22405416698678,6.72055820285909,0.139034666184972,0.160192115387033,"3265"
"GO:0043123~positive regulation of canonical NF-kappaB signal transduction",0.00413223140495868,7.09379963923268,6.60367892976589,0.141326224392168,0.162579935657347,"2280"
"hsa04810_Regulation_of_actin_cytoskeleton",0.00409836065573771,7.031927714967,6.54675066312997,0.14246989099242,0.163388963085589,"3265"
"hsa04820_Cytoskeleton_in_muscle_cells",0.00409836065573771,7.031927714967,6.54675066312997,0.14246989099242,0.163388963085589,"2023"
"hsa04714_Thermogenesis",0.00408163265306122,7.00139441855984,6.51865302079894,0.143041196861179,0.16379100010956,"3265"
"GO:0005085~guanyl-nucleotide exchange factor activity",0.0040650406504065,6.97112470338704,6.49079552925707,0.143612151373316,0.164191396485363,"440193"
"GO:0051726~regulation of cell cycle",0.00403225806451613,6.91136178711096,6.4357887874837,0.144753007119976,0.164987298437822,"3265"
"GO:0000287~magnesium ion binding",0.00403225806451613,6.91136178711096,6.4357887874837,0.144753007119976,0.164987298437822,"2023"
"hsa04014_Ras_signaling_pathway",0.004,6.85261109428618,6.38170652876535,0.145892459815899,0.166030989545087,"3265"
"hsa05022_Pathways_of_neurodegeneration",0.0040650406504065,7.3047450420906,6.31536862306093,0.0386801080209325,0.0679051895618566,"1452, 3265"
"GO:0003729~mRNA binding",0.00387596899224806,6.62639659484746,6.17417135709819,0.150436271705382,0.167399550745863,"23521"
"GO:0008284~positive regulation of cell population proliferation",0.00396825396825397,7.1223874746137,6.16164768294586,0.0404564024634239,0.0699165509927862,"282991, 3265"
"GO:0004711~ribosomal protein S6 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0044022~histone H3S28 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0044023~histone H4S1 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0004676~3-phosphoinositide-dependent protein kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0072371~histone H2AS121 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0072354~histone H3T3 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0044024~histone H2AS1 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:1990244~histone H2AT120 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0140855~histone H3S57 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0035175~histone H3S10 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0072518~Rho-dependent protein serine/threonine kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0035979~histone H2AXS139 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0140823~histone H2BS36 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"GO:0044025~histone H2BS14 kinase activity",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"1452"
"WP382:MAPK signaling",0.00386100386100386,6.59912606305612,6.14917471192775,0.151002676570648,0.167399550745863,"3265"
"GO:0004677~DNA-dependent protein kinase activity",0.00384615384615385,6.57207625041479,6.12437965260546,0.151568732843321,0.167399550745863,"1452"
"GO:0140857~histone H3T45 kinase activity",0.00384615384615385,6.57207625041479,6.12437965260546,0.151568732843321,0.167399550745863,"1452"
"GO:0035403~histone H3T6 kinase activity",0.00383141762452107,6.54524449564707,6.09978375038616,0.152134440720074,0.167483316044948,"1452"
"GO:0035402~histone H3T11 kinase activity",0.00383141762452107,6.54524449564707,6.09978375038616,0.152134440720074,0.167483316044948,"1452"
"GO:0043066~negative regulation of apoptotic process",0.00392156862745098,7.0345018845745,6.08755973485432,0.0413563476653882,0.0705434711901565,"192286, 54469"
"GO:0004679~AMP-activated protein kinase activity",0.00381679389312977,6.51862818029175,6.07538461538462,0.152699800397476,0.167856669473967,"1452"
"hsa04144_Endocytosis",0.00380228136882129,6.49222472781651,6.05117989580141,0.153264812072,0.16798004513652,"3265"
"hsa05132_Salmonella_infection",0.00380228136882129,6.49222472781651,6.05117989580141,0.153264812072,0.16798004513652,"3265"
"GO:0010629~negative regulation of gene expression",0.00378787878787879,6.46603160275359,6.02716727716728,0.153829475940013,0.168350252429926,"3265"
"GO:0030335~positive regulation of cell migration",0.00357142857142857,6.0736841039246,5.66733639494834,0.162816955990742,0.177401147349677,"3265"
"R-HSA-5673001~RAF/MAP kinase cascade",0.00355871886120996,6.0507180671671,5.64626822991135,0.16337573709523,0.177748969097743,"3265"
"GO:0001227~DNA-binding transcription repressor activity, RNA polymerase II-specific",0.00352112676056338,5.98283693222367,5.58399321266968,0.165050015452238,0.179307630257043,"2023"
"GO:0008017~microtubule binding",0.0034965034965035,5.93841165311023,5.54323413812465,0.166164482169916,0.179991307693544,"440193"
"R-HSA-5684996~MAPK1/MAPK3 signaling",0.0034965034965035,5.93841165311023,5.54323413812465,0.166164482169916,0.179991307693544,"3265"
"R-HSA-112315~Transmission across Chemical Synapses",0.00344827586206897,5.85148546669449,5.46347537354732,0.16838929734371,0.182135362432992,"3265"
"GO:0006468~protein phosphorylation",0.00342465753424658,5.80895691022492,5.42445054945055,0.169499648900872,0.183069489788133,"1452"
"KW-0498~Mitosis",0.00328947368421053,5.56674015513293,5.20152792413066,0.176133071259962,0.189957469294901,"1452"
"R-HSA-9006931~Signaling by Nuclear Receptors",0.00323624595469256,5.47134343734567,5.11396011396011,0.178882534876407,0.1926427298669,"3265"
"GO:0004672~protein kinase activity",0.00321543408360129,5.43404545935908,5.07975302289684,0.179979946808266,0.193543652944541,"1452"
"hsa04010_MAPK_signaling_pathway",0.00320512820512821,5.41553505168493,5.06282051282051,0.180528144930836,0.193852219303445,"3265"
"WP3932:Focal adhesion PI3K Akt mTOR signaling",0.00317460317460317,5.36036064533632,5.01269357705001,0.182170710222666,0.195333333793668,"3265"
"R-HSA-1643685~Disease",0.00322927879440258,8.30804935772766,4.92332626854507,0.000646537242584688,0.0249774637888529,"1452, 2023, 2280, 23521, 3265, 6208"
"GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process",0.0031055900621118,5.23783894956989,4.89950372208437,0.185991550824389,0.199142468559447,"1452"
"R-HSA-5683057~MAPK family signaling cascades",0.00306748466257669,5.16855327752969,4.83708966193043,0.188167483371347,0.201181949080028,"3265"
"GO:0045296~cadherin binding",0.00302114803625378,5.08625518639541,4.76127320954907,0.19087984865833,0.203788270078389,"2023"
"GO:0016787~hydrolase activity",0.00298507462686567,5.02217010165178,4.7023100738271,0.193043715376504,0.205802351737594,"5223"
"GO:0003924~GTPase activity",0.0028735632183908,4.8241728542564,4.52037545787546,0.200039445569146,0.212954474336164,"3265"
"WP4172:PI3K Akt signaling",0.00284900284900285,4.78024671762459,4.48037213523939,0.20164587429832,0.214357075543487,"3265"
"GO:0000977~RNA polymerase II transcription regulatory region sequence-specific DNA binding",0.0028328611898017,4.75145045585724,4.45409429280397,0.20271517189533,0.215185490051981,"2023"
"R-HSA-8953854~Metabolism of RNA",0.00275482093663912,4.84850300332367,4.24852071005917,0.0784518934595656,0.102484691808094,"23521, 6208"
"hsa04151_PI3K-Akt_signaling_pathway",0.00267379679144385,4.47088958821163,4.19570760730982,0.213863257123626,0.226371664458959,"3265"
"GO:0106310~protein serine kinase activity",0.00266666666666667,4.45830702786202,4.18414918414918,0.214390511813684,0.226606495392812,"1452"
"R-HSA-1430728~Metabolism",0.0027359781121751,6.90052049360906,4.16883665282567,0.00157323566165864,0.0249774637888529,"192286, 2023, 23521, 2805, 5223, 6208"
"GO:0004674~protein serine/threonine kinase activity",0.00259067357512953,4.32448787596124,4.06108597285068,0.220168809090733,0.23238301044854,"1452"
"GO:0005525~GTP binding",0.00252525252525253,4.20901558724566,3.95532852564103,0.225387737337355,0.237553552704997,"3265"
"GO:0051301~cell division",0.0025,4.16496270175915,3.91455194290246,0.227466266420604,0.239404212317856,"1452"
"R-HSA-1280218~Adaptive Immune System",0.00252844500632111,4.42886361307922,3.89447731755424,0.0911668290686478,0.114073840082524,"2280, 3265"
"KW-0723~Serine/threonine-protein kinase",0.00248138957816377,4.13229087613816,3.88451701750934,0.229021783308716,0.240699947896696,"1452"
"GO:0008285~negative regulation of cell population proliferation",0.0024390243902439,4.0579816072477,3.81619636644762,0.232640086146486,0.244156922094332,"3265"
"R-HSA-2262752~Cellular responses to stress",0.00245098039215686,4.28535820553616,3.77353081700908,0.0962191952967366,0.119389034966854,"23521, 6208"
"KW-0132~Cell division",0.00234192037470726,3.88803793731115,3.6598702502317,0.241362234059259,0.252953075807867,"1452"
"R-HSA-112316~Neuronal System",0.00231481481481481,3.84070294423839,3.61630036630037,0.243910100674887,0.255262756982745,"3265"
"R-HSA-8953897~Cellular responses to stimuli",0.00215749730312837,3.74265294472145,3.31625797783003,0.119621284917906,0.142929135924455,"23521, 6208"
"GO:0000122~negative regulation of transcription by RNA polymerase II",0.00207684319833853,3.59420854681493,3.19085326438268,0.12751763143972,0.149239877804846,"2023, 6208"
"GO:0003723~RNA binding",0.00205479452054795,3.79031601597731,3.14244031830239,0.0648967356455658,0.0910271792986953,"2023, 23521, 6208"
"R-HSA-1266738~Developmental Biology",0.00204638472032742,3.77345855269983,3.12949070160609,0.0655540442567151,0.0916028264378203,"23521, 3265, 6208"
"GO:0015031~protein transport",0.00200803212851406,3.30664655068092,3.12519784742007,0.27680998039007,0.289285923168214,"54469"
"R-HSA-6798695~Neutrophil degranulation",0.002,3.2927250507584,3.11238965952081,0.277785995878293,0.289897621577627,"5223"
"GO:0019901~protein kinase binding",0.00198807157057654,3.27205580985097,3.09337302208993,0.279247739490095,0.291013795929284,"5223"
"WP5434:Cancer pathways",0.00191938579654511,3.15316588658212,2.98398065588635,0.287961005710825,0.299673304680831,"3265"
"hsa01100_Metabolic_pathways",0.0019047619047619,3.48937989798497,2.911526173507,0.0780576456341921,0.102149511570671,"2023, 2805, 5223"
"hsa05200_Pathways_in_cancer",0.00183823529411765,3.01300860381195,2.85497397339503,0.298953128357228,0.310676780449668,"3265"
"R-HSA-9006934~Signaling by Receptor Tyrosine Kinases",0.00183150183150183,3.00139236909185,2.84428118697782,0.299901524037999,0.31122647669398,"3265"
"R-HSA-168249~Innate Immune System",0.00183992640294388,3.15829848868315,2.82313411495568,0.155680408660869,0.170124982660331,"3265, 5223"
"GO:0045892~negative regulation of DNA-templated transcription",0.00171526586620926,2.80119683022913,2.65997575104405,0.317234620511207,0.328295799747999,"2023"
"KW-0053~Apoptosis",0.00168918918918919,2.75624198333561,2.61870026525199,0.321390447507115,0.332133303691197,"54469"
"R-HSA-109582~Hemostasis",0.00155763239875389,2.5308459595756,2.41086691086691,0.344056297037219,0.354536451024091,"3265"
"KW-0678~Repressor",0.0015552099533437,2.52671038943332,2.4070462026088,0.344502400523409,0.354536451024091,"2023"
"R-HSA-388396~GPCR downstream signalling",0.00153846153846154,2.49772406194749,2.38063660477454,0.34761729201094,0.357207994901351,"3265"
"KW-0653~Protein transport",0.00153609831029186,2.49368760613162,2.37691103888287,0.348061159452394,0.357207994901351,"54469"
"GO:0007165~signal transduction",0.00153491941673062,2.59907398217568,2.35115503691355,0.20745806065526,0.219905544294576,"1452, 3265"
"GO:0006915~apoptotic process",0.00151745068285281,2.46182974787954,2.34752110331708,0.351602076303777,0.360343564388677,"54469"
"R-HSA-162582~Signal Transduction",0.0015220700152207,2.90897598582236,2.31973448468294,0.0823957522747867,0.106511582208871,"1452, 2280, 3265, 440193"
"GO:0006338~chromatin remodeling",0.00144508670520231,2.33820903217387,2.23359728506787,0.366021526550944,0.374604100276967,"1452"
"KW-0131~Cell cycle",0.00143884892086331,2.32755303312133,2.22378646243946,0.367317597885409,0.375412751557815,"1452"
"R-HSA-168256~Immune System",0.0014292520247737,2.53760583488656,2.18120558235446,0.15160714029814,0.167399550745863,"2280, 3265, 5223"
"GO:0045893~positive regulation of DNA-templated transcription",0.00137931034482759,2.226021775301,2.1302190096019,0.380144467213217,0.387454937736548,"282991"
"R-HSA-392499~Metabolism of proteins",0.00139599813866915,2.47137496338312,2.1302190096019,0.159634114026724,0.17418898912916,"23521, 6208, 64981"
"R-HSA-372790~Signaling by GPCR",0.00137931034482759,2.226021775301,2.1302190096019,0.380144467213217,0.387454937736548,"3265"
"KW-0418~Kinase",0.00133511348464619,2.1506500752163,2.06084959816303,0.390232659972068,0.396647443423664,"1452"
"GO:0042803~protein homodimerization activity",0.00131752305665349,2.12074418479836,2.03326125012872,0.394391166466867,0.400325917261854,"2023"
"R-HSA-1280215~Cytokine Signaling in Immune system",0.00124223602484472,1.99275220636185,1.91531671355127,0.413185267875286,0.418258483988352,"3265"
"GO:0006357~regulation of transcription by RNA polymerase II",0.00118063754427391,1.95237079353314,1.80492709904475,0.30551256132041,0.316606592876738,"2280, 3265"
"KW-0378~Hydrolase",0.0011037527593819,1.81234939868131,1.68666979882971,0.335294015335321,0.346019693155505,"3265, 5223"
"KW-0808~Transferase",0.000986193293885602,1.59858860593412,1.50604477327333,0.389193976182258,0.396134335153958,"1452, 2805"
"KW-0813~Transport",0.000968054211035818,1.56563457981595,1.47819577016657,0.398547949497119,0.403992593615932,"192286, 54469"
"GO:0045944~positive regulation of transcription by RNA polymerase II",0.000830564784053156,1.2972783340744,1.2741997934951,0.555029919222337,0.561079291638929,"3265"
"GO:0003677~DNA binding",0.000687757909215956,1.05779210461815,1.05329136882535,0.62699760803481,0.632109001578572,"54469"
"GO:0005524~ATP binding",0.000662690523525514,1.01582122719947,1.01459328914239,0.641313576071498,0.64566441444376,"1452"
"GO:0005515~protein binding",0.000662544169611307,1.02147384241414,1.00659907103206,0.617205923265207,0.623084074915352,"1452, 2023, 2280, 282991, 3265, 440193, 5223, 54469, 6208"
"GO:0042802~identical protein binding",0.000563063063063063,0.849351418223938,0.861023896738182,0.703879308227738,0.707694372228972,"440193"
"KW-0238~DNA-binding",0.000484496124031008,0.718410231570364,0.740178437546859,0.759963464876182,0.763048566898683,"2023"
"GO:0008270~zinc ion binding",0.000466635557629491,0.688665560483261,0.712738692560372,0.773533772045519,0.775624403861858,"54469"
"KW-0805~Transcription regulation",0.000417710944026733,0.607285987155163,0.637634825292256,0.812092686400309,0.813188627947408,"2023"
"KW-0804~Transcription",0.000406173842404549,0.588110668578557,0.619937205651491,0.821441132172425,0.821441132172425,"2023"
